<?xml version="1.0" encoding="UTF-8"  standalone="no" ?>
<uniprot xmlns="http://uniprot.org/uniprot" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://uniprot.org/uniprot http://www.uniprot.org/docs/uniprot.xsd">
<entry dataset="Swiss-Prot" created="1996-02-01" modified="2024-10-02" version="214" xmlns="http://uniprot.org/uniprot">
  <accession>P49588</accession>
  <accession>A6NF14</accession>
  <accession>B4DR45</accession>
  <accession>Q53GV7</accession>
  <accession>Q96FA0</accession>
  <name>SYAC_HUMAN</name>
  <protein>
    <recommendedName>
      <fullName evidence="1">Alanine--tRNA ligase, cytoplasmic</fullName>
      <ecNumber evidence="1 8 9 10 11">6.1.1.7</ecNumber>
    </recommendedName>
    <alternativeName>
      <fullName evidence="1">Alanyl-tRNA synthetase</fullName>
      <shortName evidence="1">AlaRS</shortName>
    </alternativeName>
    <alternativeName>
      <fullName evidence="25">Protein lactyltransferase AARS1</fullName>
      <ecNumber evidence="19 20">6.-.-.-</ecNumber>
    </alternativeName>
    <alternativeName>
      <fullName>Renal carcinoma antigen NY-REN-42</fullName>
    </alternativeName>
  </protein>
  <gene>
    <name evidence="24 26" type="primary">AARS1</name>
    <name evidence="1" type="synonym">AARS</name>
  </gene>
  <organism>
    <name type="scientific">Homo sapiens</name>
    <name type="common">Human</name>
    <dbReference type="NCBI Taxonomy" id="9606"/>
    <lineage>
      <taxon>Eukaryota</taxon>
      <taxon>Metazoa</taxon>
      <taxon>Chordata</taxon>
      <taxon>Craniata</taxon>
      <taxon>Vertebrata</taxon>
      <taxon>Euteleostomi</taxon>
      <taxon>Mammalia</taxon>
      <taxon>Eutheria</taxon>
      <taxon>Euarchontoglires</taxon>
      <taxon>Primates</taxon>
      <taxon>Haplorrhini</taxon>
      <taxon>Catarrhini</taxon>
      <taxon>Hominidae</taxon>
      <taxon>Homo</taxon>
    </lineage>
  </organism>
  <reference key="1">
    <citation type="journal article" date="1995" name="Biochemistry" volume="34" first="10340" last="10349">
      <title>Human alanyl-tRNA synthetase: conservation in evolution of catalytic core and microhelix recognition.</title>
      <authorList>
        <person name="Shiba K."/>
        <person name="Ripmaster T.L."/>
        <person name="Suzuki N."/>
        <person name="Nichols R."/>
        <person name="Plotz P."/>
        <person name="Noda T."/>
        <person name="Schimmel P."/>
      </authorList>
      <dbReference type="PubMed" id="7654687"/>
      <dbReference type="DOI" id="10.1021/bi00033a004"/>
    </citation>
    <scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1)</scope>
  </reference>
  <reference key="2">
    <citation type="journal article" date="2004" name="Nat. Genet." volume="36" first="40" last="45">
      <title>Complete sequencing and characterization of 21,243 full-length human cDNAs.</title>
      <authorList>
        <person name="Ota T."/>
        <person name="Suzuki Y."/>
        <person name="Nishikawa T."/>
        <person name="Otsuki T."/>
        <person name="Sugiyama T."/>
        <person name="Irie R."/>
        <person name="Wakamatsu A."/>
        <person name="Hayashi K."/>
        <person name="Sato H."/>
        <person name="Nagai K."/>
        <person name="Kimura K."/>
        <person name="Makita H."/>
        <person name="Sekine M."/>
        <person name="Obayashi M."/>
        <person name="Nishi T."/>
        <person name="Shibahara T."/>
        <person name="Tanaka T."/>
        <person name="Ishii S."/>
        <person name="Yamamoto J."/>
        <person name="Saito K."/>
        <person name="Kawai Y."/>
        <person name="Isono Y."/>
        <person name="Nakamura Y."/>
        <person name="Nagahari K."/>
        <person name="Murakami K."/>
        <person name="Yasuda T."/>
        <person name="Iwayanagi T."/>
        <person name="Wagatsuma M."/>
        <person name="Shiratori A."/>
        <person name="Sudo H."/>
        <person name="Hosoiri T."/>
        <person name="Kaku Y."/>
        <person name="Kodaira H."/>
        <person name="Kondo H."/>
        <person name="Sugawara M."/>
        <person name="Takahashi M."/>
        <person name="Kanda K."/>
        <person name="Yokoi T."/>
        <person name="Furuya T."/>
        <person name="Kikkawa E."/>
        <person name="Omura Y."/>
        <person name="Abe K."/>
        <person name="Kamihara K."/>
        <person name="Katsuta N."/>
        <person name="Sato K."/>
        <person name="Tanikawa M."/>
        <person name="Yamazaki M."/>
        <person name="Ninomiya K."/>
        <person name="Ishibashi T."/>
        <person name="Yamashita H."/>
        <person name="Murakawa K."/>
        <person name="Fujimori K."/>
        <person name="Tanai H."/>
        <person name="Kimata M."/>
        <person name="Watanabe M."/>
        <person name="Hiraoka S."/>
        <person name="Chiba Y."/>
        <person name="Ishida S."/>
        <person name="Ono Y."/>
        <person name="Takiguchi S."/>
        <person name="Watanabe S."/>
        <person name="Yosida M."/>
        <person name="Hotuta T."/>
        <person name="Kusano J."/>
        <person name="Kanehori K."/>
        <person name="Takahashi-Fujii A."/>
        <person name="Hara H."/>
        <person name="Tanase T.-O."/>
        <person name="Nomura Y."/>
        <person name="Togiya S."/>
        <person name="Komai F."/>
        <person name="Hara R."/>
        <person name="Takeuchi K."/>
        <person name="Arita M."/>
        <person name="Imose N."/>
        <person name="Musashino K."/>
        <person name="Yuuki H."/>
        <person name="Oshima A."/>
        <person name="Sasaki N."/>
        <person name="Aotsuka S."/>
        <person name="Yoshikawa Y."/>
        <person name="Matsunawa H."/>
        <person name="Ichihara T."/>
        <person name="Shiohata N."/>
        <person name="Sano S."/>
        <person name="Moriya S."/>
        <person name="Momiyama H."/>
        <person name="Satoh N."/>
        <person name="Takami S."/>
        <person name="Terashima Y."/>
        <person name="Suzuki O."/>
        <person name="Nakagawa S."/>
        <person name="Senoh A."/>
        <person name="Mizoguchi H."/>
        <person name="Goto Y."/>
        <person name="Shimizu F."/>
        <person name="Wakebe H."/>
        <person name="Hishigaki H."/>
        <person name="Watanabe T."/>
        <person name="Sugiyama A."/>
        <person name="Takemoto M."/>
        <person name="Kawakami B."/>
        <person name="Yamazaki M."/>
        <person name="Watanabe K."/>
        <person name="Kumagai A."/>
        <person name="Itakura S."/>
        <person name="Fukuzumi Y."/>
        <person name="Fujimori Y."/>
        <person name="Komiyama M."/>
        <person name="Tashiro H."/>
        <person name="Tanigami A."/>
        <person name="Fujiwara T."/>
        <person name="Ono T."/>
        <person name="Yamada K."/>
        <person name="Fujii Y."/>
        <person name="Ozaki K."/>
        <person name="Hirao M."/>
        <person name="Ohmori Y."/>
        <person name="Kawabata A."/>
        <person name="Hikiji T."/>
        <person name="Kobatake N."/>
        <person name="Inagaki H."/>
        <person name="Ikema Y."/>
        <person name="Okamoto S."/>
        <person name="Okitani R."/>
        <person name="Kawakami T."/>
        <person name="Noguchi S."/>
        <person name="Itoh T."/>
        <person name="Shigeta K."/>
        <person name="Senba T."/>
        <person name="Matsumura K."/>
        <person name="Nakajima Y."/>
        <person name="Mizuno T."/>
        <person name="Morinaga M."/>
        <person name="Sasaki M."/>
        <person name="Togashi T."/>
        <person name="Oyama M."/>
        <person name="Hata H."/>
        <person name="Watanabe M."/>
        <person name="Komatsu T."/>
        <person name="Mizushima-Sugano J."/>
        <person name="Satoh T."/>
        <person name="Shirai Y."/>
        <person name="Takahashi Y."/>
        <person name="Nakagawa K."/>
        <person name="Okumura K."/>
        <person name="Nagase T."/>
        <person name="Nomura N."/>
        <person name="Kikuchi H."/>
        <person name="Masuho Y."/>
        <person name="Yamashita R."/>
        <person name="Nakai K."/>
        <person name="Yada T."/>
        <person name="Nakamura Y."/>
        <person name="Ohara O."/>
        <person name="Isogai T."/>
        <person name="Sugano S."/>
      </authorList>
      <dbReference type="PubMed" id="14702039"/>
      <dbReference type="DOI" id="10.1038/ng1285"/>
    </citation>
    <scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2)</scope>
  </reference>
  <reference key="3">
    <citation type="submission" date="2005-04" db="EMBL/GenBank/DDBJ databases">
      <authorList>
        <person name="Suzuki Y."/>
        <person name="Sugano S."/>
        <person name="Totoki Y."/>
        <person name="Toyoda A."/>
        <person name="Takeda T."/>
        <person name="Sakaki Y."/>
        <person name="Tanaka A."/>
        <person name="Yokoyama S."/>
      </authorList>
    </citation>
    <scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1)</scope>
    <source>
      <tissue>Liver</tissue>
    </source>
  </reference>
  <reference key="4">
    <citation type="journal article" date="2004" name="Nature" volume="432" first="988" last="994">
      <title>The sequence and analysis of duplication-rich human chromosome 16.</title>
      <authorList>
        <person name="Martin J."/>
        <person name="Han C."/>
        <person name="Gordon L.A."/>
        <person name="Terry A."/>
        <person name="Prabhakar S."/>
        <person name="She X."/>
        <person name="Xie G."/>
        <person name="Hellsten U."/>
        <person name="Chan Y.M."/>
        <person name="Altherr M."/>
        <person name="Couronne O."/>
        <person name="Aerts A."/>
        <person name="Bajorek E."/>
        <person name="Black S."/>
        <person name="Blumer H."/>
        <person name="Branscomb E."/>
        <person name="Brown N.C."/>
        <person name="Bruno W.J."/>
        <person name="Buckingham J.M."/>
        <person name="Callen D.F."/>
        <person name="Campbell C.S."/>
        <person name="Campbell M.L."/>
        <person name="Campbell E.W."/>
        <person name="Caoile C."/>
        <person name="Challacombe J.F."/>
        <person name="Chasteen L.A."/>
        <person name="Chertkov O."/>
        <person name="Chi H.C."/>
        <person name="Christensen M."/>
        <person name="Clark L.M."/>
        <person name="Cohn J.D."/>
        <person name="Denys M."/>
        <person name="Detter J.C."/>
        <person name="Dickson M."/>
        <person name="Dimitrijevic-Bussod M."/>
        <person name="Escobar J."/>
        <person name="Fawcett J.J."/>
        <person name="Flowers D."/>
        <person name="Fotopulos D."/>
        <person name="Glavina T."/>
        <person name="Gomez M."/>
        <person name="Gonzales E."/>
        <person name="Goodstein D."/>
        <person name="Goodwin L.A."/>
        <person name="Grady D.L."/>
        <person name="Grigoriev I."/>
        <person name="Groza M."/>
        <person name="Hammon N."/>
        <person name="Hawkins T."/>
        <person name="Haydu L."/>
        <person name="Hildebrand C.E."/>
        <person name="Huang W."/>
        <person name="Israni S."/>
        <person name="Jett J."/>
        <person name="Jewett P.B."/>
        <person name="Kadner K."/>
        <person name="Kimball H."/>
        <person name="Kobayashi A."/>
        <person name="Krawczyk M.-C."/>
        <person name="Leyba T."/>
        <person name="Longmire J.L."/>
        <person name="Lopez F."/>
        <person name="Lou Y."/>
        <person name="Lowry S."/>
        <person name="Ludeman T."/>
        <person name="Manohar C.F."/>
        <person name="Mark G.A."/>
        <person name="McMurray K.L."/>
        <person name="Meincke L.J."/>
        <person name="Morgan J."/>
        <person name="Moyzis R.K."/>
        <person name="Mundt M.O."/>
        <person name="Munk A.C."/>
        <person name="Nandkeshwar R.D."/>
        <person name="Pitluck S."/>
        <person name="Pollard M."/>
        <person name="Predki P."/>
        <person name="Parson-Quintana B."/>
        <person name="Ramirez L."/>
        <person name="Rash S."/>
        <person name="Retterer J."/>
        <person name="Ricke D.O."/>
        <person name="Robinson D.L."/>
        <person name="Rodriguez A."/>
        <person name="Salamov A."/>
        <person name="Saunders E.H."/>
        <person name="Scott D."/>
        <person name="Shough T."/>
        <person name="Stallings R.L."/>
        <person name="Stalvey M."/>
        <person name="Sutherland R.D."/>
        <person name="Tapia R."/>
        <person name="Tesmer J.G."/>
        <person name="Thayer N."/>
        <person name="Thompson L.S."/>
        <person name="Tice H."/>
        <person name="Torney D.C."/>
        <person name="Tran-Gyamfi M."/>
        <person name="Tsai M."/>
        <person name="Ulanovsky L.E."/>
        <person name="Ustaszewska A."/>
        <person name="Vo N."/>
        <person name="White P.S."/>
        <person name="Williams A.L."/>
        <person name="Wills P.L."/>
        <person name="Wu J.-R."/>
        <person name="Wu K."/>
        <person name="Yang J."/>
        <person name="DeJong P."/>
        <person name="Bruce D."/>
        <person name="Doggett N.A."/>
        <person name="Deaven L."/>
        <person name="Schmutz J."/>
        <person name="Grimwood J."/>
        <person name="Richardson P."/>
        <person name="Rokhsar D.S."/>
        <person name="Eichler E.E."/>
        <person name="Gilna P."/>
        <person name="Lucas S.M."/>
        <person name="Myers R.M."/>
        <person name="Rubin E.M."/>
        <person name="Pennacchio L.A."/>
      </authorList>
      <dbReference type="PubMed" id="15616553"/>
      <dbReference type="DOI" id="10.1038/nature03187"/>
    </citation>
    <scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
  </reference>
  <reference key="5">
    <citation type="submission" date="2005-07" db="EMBL/GenBank/DDBJ databases">
      <authorList>
        <person name="Mural R.J."/>
        <person name="Istrail S."/>
        <person name="Sutton G.G."/>
        <person name="Florea L."/>
        <person name="Halpern A.L."/>
        <person name="Mobarry C.M."/>
        <person name="Lippert R."/>
        <person name="Walenz B."/>
        <person name="Shatkay H."/>
        <person name="Dew I."/>
        <person name="Miller J.R."/>
        <person name="Flanigan M.J."/>
        <person name="Edwards N.J."/>
        <person name="Bolanos R."/>
        <person name="Fasulo D."/>
        <person name="Halldorsson B.V."/>
        <person name="Hannenhalli S."/>
        <person name="Turner R."/>
        <person name="Yooseph S."/>
        <person name="Lu F."/>
        <person name="Nusskern D.R."/>
        <person name="Shue B.C."/>
        <person name="Zheng X.H."/>
        <person name="Zhong F."/>
        <person name="Delcher A.L."/>
        <person name="Huson D.H."/>
        <person name="Kravitz S.A."/>
        <person name="Mouchard L."/>
        <person name="Reinert K."/>
        <person name="Remington K.A."/>
        <person name="Clark A.G."/>
        <person name="Waterman M.S."/>
        <person name="Eichler E.E."/>
        <person name="Adams M.D."/>
        <person name="Hunkapiller M.W."/>
        <person name="Myers E.W."/>
        <person name="Venter J.C."/>
      </authorList>
    </citation>
    <scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
  </reference>
  <reference key="6">
    <citation type="journal article" date="2004" name="Genome Res." volume="14" first="2121" last="2127">
      <title>The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).</title>
      <authorList>
        <consortium name="The MGC Project Team"/>
      </authorList>
      <dbReference type="PubMed" id="15489334"/>
      <dbReference type="DOI" id="10.1101/gr.2596504"/>
    </citation>
    <scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1)</scope>
    <source>
      <tissue>Placenta</tissue>
    </source>
  </reference>
  <reference key="7">
    <citation type="submission" date="2007-07" db="UniProtKB">
      <authorList>
        <person name="Bienvenut W.V."/>
        <person name="Glen H."/>
        <person name="Brunton V.G."/>
        <person name="Frame M.C."/>
      </authorList>
    </citation>
    <scope>PROTEIN SEQUENCE OF 1-11; 304-320 AND 684-695</scope>
    <scope>ACETYLATION AT MET-1</scope>
    <scope>IDENTIFICATION BY MASS SPECTROMETRY</scope>
    <source>
      <tissue>Osteosarcoma</tissue>
    </source>
  </reference>
  <reference key="8">
    <citation type="journal article" date="1999" name="Int. J. Cancer" volume="83" first="456" last="464">
      <title>Antigens recognized by autologous antibody in patients with renal-cell carcinoma.</title>
      <authorList>
        <person name="Scanlan M.J."/>
        <person name="Gordan J.D."/>
        <person name="Williamson B."/>
        <person name="Stockert E."/>
        <person name="Bander N.H."/>
        <person name="Jongeneel C.V."/>
        <person name="Gure A.O."/>
        <person name="Jaeger D."/>
        <person name="Jaeger E."/>
        <person name="Knuth A."/>
        <person name="Chen Y.-T."/>
        <person name="Old L.J."/>
      </authorList>
      <dbReference type="PubMed" id="10508479"/>
      <dbReference type="DOI" id="10.1002/(sici)1097-0215(19991112)83:4&lt;456::aid-ijc4&gt;3.0.co;2-5"/>
    </citation>
    <scope>IDENTIFICATION AS A RENAL CANCER ANTIGEN</scope>
    <source>
      <tissue>Renal cell carcinoma</tissue>
    </source>
  </reference>
  <reference key="9">
    <citation type="journal article" date="2005" name="Biochem. Biophys. Res. Commun." volume="336" first="496" last="506">
      <title>Proteomic identification of proteins conjugated to ISG15 in mouse and human cells.</title>
      <authorList>
        <person name="Giannakopoulos N.V."/>
        <person name="Luo J.K."/>
        <person name="Papov V."/>
        <person name="Zou W."/>
        <person name="Lenschow D.J."/>
        <person name="Jacobs B.S."/>
        <person name="Borden E.C."/>
        <person name="Li J."/>
        <person name="Virgin H.W."/>
        <person name="Zhang D.E."/>
      </authorList>
      <dbReference type="PubMed" id="16139798"/>
      <dbReference type="DOI" id="10.1016/j.bbrc.2005.08.132"/>
    </citation>
    <scope>ISGYLATION</scope>
  </reference>
  <reference key="10">
    <citation type="journal article" date="2008" name="Proc. Natl. Acad. Sci. U.S.A." volume="105" first="10762" last="10767">
      <title>A quantitative atlas of mitotic phosphorylation.</title>
      <authorList>
        <person name="Dephoure N."/>
        <person name="Zhou C."/>
        <person name="Villen J."/>
        <person name="Beausoleil S.A."/>
        <person name="Bakalarski C.E."/>
        <person name="Elledge S.J."/>
        <person name="Gygi S.P."/>
      </authorList>
      <dbReference type="PubMed" id="18669648"/>
      <dbReference type="DOI" id="10.1073/pnas.0805139105"/>
    </citation>
    <scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-555</scope>
    <scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
    <source>
      <tissue>Cervix carcinoma</tissue>
    </source>
  </reference>
  <reference key="11">
    <citation type="journal article" date="2009" name="Anal. Chem." volume="81" first="4493" last="4501">
      <title>Lys-N and trypsin cover complementary parts of the phosphoproteome in a refined SCX-based approach.</title>
      <authorList>
        <person name="Gauci S."/>
        <person name="Helbig A.O."/>
        <person name="Slijper M."/>
        <person name="Krijgsveld J."/>
        <person name="Heck A.J."/>
        <person name="Mohammed S."/>
      </authorList>
      <dbReference type="PubMed" id="19413330"/>
      <dbReference type="DOI" id="10.1021/ac9004309"/>
    </citation>
    <scope>ACETYLATION [LARGE SCALE ANALYSIS] AT MET-1</scope>
    <scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
  </reference>
  <reference key="12">
    <citation type="journal article" date="2009" name="Science" volume="325" first="744" last="747">
      <title>The C-Ala domain brings together editing and aminoacylation functions on one tRNA.</title>
      <authorList>
        <person name="Guo M."/>
        <person name="Chong Y.E."/>
        <person name="Beebe K."/>
        <person name="Shapiro R."/>
        <person name="Yang X.-L."/>
        <person name="Schimmel P."/>
      </authorList>
      <dbReference type="PubMed" id="19661429"/>
      <dbReference type="DOI" id="10.1126/science.1174343"/>
    </citation>
    <scope>DOMAIN EXCHANGE EXPERIMENTS</scope>
  </reference>
  <reference key="13">
    <citation type="journal article" date="2009" name="Science" volume="325" first="834" last="840">
      <title>Lysine acetylation targets protein complexes and co-regulates major cellular functions.</title>
      <authorList>
        <person name="Choudhary C."/>
        <person name="Kumar C."/>
        <person name="Gnad F."/>
        <person name="Nielsen M.L."/>
        <person name="Rehman M."/>
        <person name="Walther T.C."/>
        <person name="Olsen J.V."/>
        <person name="Mann M."/>
      </authorList>
      <dbReference type="PubMed" id="19608861"/>
      <dbReference type="DOI" id="10.1126/science.1175371"/>
    </citation>
    <scope>ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-19 AND LYS-876</scope>
    <scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
  </reference>
  <reference key="14">
    <citation type="journal article" date="2010" name="Sci. Signal." volume="3" first="RA3" last="RA3">
      <title>Quantitative phosphoproteomics reveals widespread full phosphorylation site occupancy during mitosis.</title>
      <authorList>
        <person name="Olsen J.V."/>
        <person name="Vermeulen M."/>
        <person name="Santamaria A."/>
        <person name="Kumar C."/>
        <person name="Miller M.L."/>
        <person name="Jensen L.J."/>
        <person name="Gnad F."/>
        <person name="Cox J."/>
        <person name="Jensen T.S."/>
        <person name="Nigg E.A."/>
        <person name="Brunak S."/>
        <person name="Mann M."/>
      </authorList>
      <dbReference type="PubMed" id="20068231"/>
      <dbReference type="DOI" id="10.1126/scisignal.2000475"/>
    </citation>
    <scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-399</scope>
    <scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
    <source>
      <tissue>Cervix carcinoma</tissue>
    </source>
  </reference>
  <reference key="15">
    <citation type="journal article" date="2011" name="BMC Syst. Biol." volume="5" first="17" last="17">
      <title>Initial characterization of the human central proteome.</title>
      <authorList>
        <person name="Burkard T.R."/>
        <person name="Planyavsky M."/>
        <person name="Kaupe I."/>
        <person name="Breitwieser F.P."/>
        <person name="Buerckstuemmer T."/>
        <person name="Bennett K.L."/>
        <person name="Superti-Furga G."/>
        <person name="Colinge J."/>
      </authorList>
      <dbReference type="PubMed" id="21269460"/>
      <dbReference type="DOI" id="10.1186/1752-0509-5-17"/>
    </citation>
    <scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
  </reference>
  <reference key="16">
    <citation type="journal article" date="2012" name="Mol. Cell. Proteomics" volume="11" first="M111.015131" last="M111.015131">
      <title>Comparative large-scale characterisation of plant vs. mammal proteins reveals similar and idiosyncratic N-alpha acetylation features.</title>
      <authorList>
        <person name="Bienvenut W.V."/>
        <person name="Sumpton D."/>
        <person name="Martinez A."/>
        <person name="Lilla S."/>
        <person name="Espagne C."/>
        <person name="Meinnel T."/>
        <person name="Giglione C."/>
      </authorList>
      <dbReference type="PubMed" id="22223895"/>
      <dbReference type="DOI" id="10.1074/mcp.m111.015131"/>
    </citation>
    <scope>ACETYLATION [LARGE SCALE ANALYSIS] AT MET-1</scope>
    <scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
  </reference>
  <reference key="17">
    <citation type="journal article" date="2012" name="Proc. Natl. Acad. Sci. U.S.A." volume="109" first="12449" last="12454">
      <title>N-terminal acetylome analyses and functional insights of the N-terminal acetyltransferase NatB.</title>
      <authorList>
        <person name="Van Damme P."/>
        <person name="Lasa M."/>
        <person name="Polevoda B."/>
        <person name="Gazquez C."/>
        <person name="Elosegui-Artola A."/>
        <person name="Kim D.S."/>
        <person name="De Juan-Pardo E."/>
        <person name="Demeyer K."/>
        <person name="Hole K."/>
        <person name="Larrea E."/>
        <person name="Timmerman E."/>
        <person name="Prieto J."/>
        <person name="Arnesen T."/>
        <person name="Sherman F."/>
        <person name="Gevaert K."/>
        <person name="Aldabe R."/>
      </authorList>
      <dbReference type="PubMed" id="22814378"/>
      <dbReference type="DOI" id="10.1073/pnas.1210303109"/>
    </citation>
    <scope>ACETYLATION [LARGE SCALE ANALYSIS] AT MET-1</scope>
    <scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
  </reference>
  <reference key="18">
    <citation type="journal article" date="2013" name="J. Proteome Res." volume="12" first="260" last="271">
      <title>Toward a comprehensive characterization of a human cancer cell phosphoproteome.</title>
      <authorList>
        <person name="Zhou H."/>
        <person name="Di Palma S."/>
        <person name="Preisinger C."/>
        <person name="Peng M."/>
        <person name="Polat A.N."/>
        <person name="Heck A.J."/>
        <person name="Mohammed S."/>
      </authorList>
      <dbReference type="PubMed" id="23186163"/>
      <dbReference type="DOI" id="10.1021/pr300630k"/>
    </citation>
    <scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-3; SER-8 AND SER-555</scope>
    <scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
    <source>
      <tissue>Cervix carcinoma</tissue>
      <tissue>Erythroleukemia</tissue>
    </source>
  </reference>
  <reference key="19">
    <citation type="journal article" date="2014" name="J. Proteomics" volume="96" first="253" last="262">
      <title>An enzyme assisted RP-RPLC approach for in-depth analysis of human liver phosphoproteome.</title>
      <authorList>
        <person name="Bian Y."/>
        <person name="Song C."/>
        <person name="Cheng K."/>
        <person name="Dong M."/>
        <person name="Wang F."/>
        <person name="Huang J."/>
        <person name="Sun D."/>
        <person name="Wang L."/>
        <person name="Ye M."/>
        <person name="Zou H."/>
      </authorList>
      <dbReference type="PubMed" id="24275569"/>
      <dbReference type="DOI" id="10.1016/j.jprot.2013.11.014"/>
    </citation>
    <scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
    <source>
      <tissue>Liver</tissue>
    </source>
  </reference>
  <reference key="20">
    <citation type="journal article" date="2015" name="Am. J. Hum. Genet." volume="96" first="675" last="681">
      <title>Loss-of-function alanyl-tRNA synthetase mutations cause an autosomal-recessive early-onset epileptic encephalopathy with persistent myelination defect.</title>
      <authorList>
        <person name="Simons C."/>
        <person name="Griffin L.B."/>
        <person name="Helman G."/>
        <person name="Golas G."/>
        <person name="Pizzino A."/>
        <person name="Bloom M."/>
        <person name="Murphy J.L."/>
        <person name="Crawford J."/>
        <person name="Evans S.H."/>
        <person name="Topper S."/>
        <person name="Whitehead M.T."/>
        <person name="Schreiber J.M."/>
        <person name="Chapman K.A."/>
        <person name="Tifft C."/>
        <person name="Lu K.B."/>
        <person name="Gamper H."/>
        <person name="Shigematsu M."/>
        <person name="Taft R.J."/>
        <person name="Antonellis A."/>
        <person name="Hou Y.M."/>
        <person name="Vanderver A."/>
      </authorList>
      <dbReference type="PubMed" id="25817015"/>
      <dbReference type="DOI" id="10.1016/j.ajhg.2015.02.012"/>
    </citation>
    <scope>BIOPHYSICOCHEMICAL PROPERTIES</scope>
    <scope>INVOLVEMENT IN DEE29</scope>
    <scope>VARIANTS DEE29 THR-81 AND GLY-751</scope>
    <scope>CHARACTERIZATION OF VARIANTS DEE29 THR-81 AND GLY-751</scope>
    <scope>CATALYTIC ACTIVITY</scope>
  </reference>
  <reference key="21">
    <citation type="journal article" date="2015" name="Proteomics" volume="15" first="2519" last="2524">
      <title>N-terminome analysis of the human mitochondrial proteome.</title>
      <authorList>
        <person name="Vaca Jacome A.S."/>
        <person name="Rabilloud T."/>
        <person name="Schaeffer-Reiss C."/>
        <person name="Rompais M."/>
        <person name="Ayoub D."/>
        <person name="Lane L."/>
        <person name="Bairoch A."/>
        <person name="Van Dorsselaer A."/>
        <person name="Carapito C."/>
      </authorList>
      <dbReference type="PubMed" id="25944712"/>
      <dbReference type="DOI" id="10.1002/pmic.201400617"/>
    </citation>
    <scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
  </reference>
  <reference key="22">
    <citation type="journal article" date="2019" name="Acta Neuropathol. Commun." volume="7" first="188" last="188">
      <title>An AARS variant as the likely cause of Swedish type hereditary diffuse leukoencephalopathy with spheroids.</title>
      <authorList>
        <person name="Sundal C."/>
        <person name="Carmona S."/>
        <person name="Yhr M."/>
        <person name="Almstroem O."/>
        <person name="Ljungberg M."/>
        <person name="Hardy J."/>
        <person name="Hedberg-Oldfors C."/>
        <person name="Fred A."/>
        <person name="Bras J."/>
        <person name="Oldfors A."/>
        <person name="Andersen O."/>
        <person name="Guerreiro R."/>
      </authorList>
      <dbReference type="PubMed" id="31775912"/>
      <dbReference type="DOI" id="10.1186/s40478-019-0843-y"/>
    </citation>
    <scope>INVOLVEMENT IN HDLS2</scope>
    <scope>VARIANT HDLS2 PHE-152</scope>
  </reference>
  <reference key="23">
    <citation type="journal article" date="2021" name="Hum. Mol. Genet." volume="30" first="1711" last="1720">
      <title>Protein instability associated with AARS1 and MARS1 mutations causes trichothiodystrophy.</title>
      <authorList>
        <person name="Botta E."/>
        <person name="Theil A.F."/>
        <person name="Raams A."/>
        <person name="Caligiuri G."/>
        <person name="Giachetti S."/>
        <person name="Bione S."/>
        <person name="Accadia M."/>
        <person name="Lombardi A."/>
        <person name="Smith D.E.C."/>
        <person name="Mendes M.I."/>
        <person name="Swagemakers S.M.A."/>
        <person name="van der Spek P.J."/>
        <person name="Salomons G.S."/>
        <person name="Hoeijmakers J.H.J."/>
        <person name="Yesodharan D."/>
        <person name="Nampoothiri S."/>
        <person name="Ogi T."/>
        <person name="Lehmann A.R."/>
        <person name="Orioli D."/>
        <person name="Vermeulen W."/>
      </authorList>
      <dbReference type="PubMed" id="33909043"/>
      <dbReference type="DOI" id="10.1093/hmg/ddab123"/>
    </citation>
    <scope>INVOLVEMENT IN TTD8</scope>
    <scope>VARIANTS TTD8 THR-699; ALA-726; ILE-756 AND TYR-901</scope>
    <scope>FUNCTION</scope>
  </reference>
  <reference key="24">
    <citation type="journal article" date="2024" name="Cell" volume="187" first="2375" last="2392">
      <title>Alanyl-tRNA synthetase, AARS1, is a lactate sensor and lactyltransferase that lactylates p53 and contributes to tumorigenesis.</title>
      <authorList>
        <person name="Zong Z."/>
        <person name="Xie F."/>
        <person name="Wang S."/>
        <person name="Wu X."/>
        <person name="Zhang Z."/>
        <person name="Yang B."/>
        <person name="Zhou F."/>
      </authorList>
      <dbReference type="PubMed" id="38653238"/>
      <dbReference type="DOI" id="10.1016/j.cell.2024.04.002"/>
    </citation>
    <scope>FUNCTION</scope>
    <scope>CATALYTIC ACTIVITY</scope>
    <scope>ACTIVITY REGULATION</scope>
    <scope>MUTAGENESIS OF MET-46; ARG-77; ASN-216 AND 239-ASP--GLY-241</scope>
  </reference>
  <reference key="25">
    <citation type="journal article" date="2024" name="J. Clin. Invest." volume="134">
      <title>The alanyl-tRNA synthetase AARS1 moonlights as a lactyltransferase to promote YAP signaling in gastric cancer.</title>
      <authorList>
        <person name="Ju J."/>
        <person name="Zhang H."/>
        <person name="Lin M."/>
        <person name="Yan Z."/>
        <person name="An L."/>
        <person name="Cao Z."/>
        <person name="Geng D."/>
        <person name="Yue J."/>
        <person name="Tang Y."/>
        <person name="Tian L."/>
        <person name="Chen F."/>
        <person name="Han Y."/>
        <person name="Wang W."/>
        <person name="Zhao S."/>
        <person name="Jiao S."/>
        <person name="Zhou Z."/>
      </authorList>
      <dbReference type="PubMed" id="38512451"/>
      <dbReference type="DOI" id="10.1172/jci174587"/>
    </citation>
    <scope>FUNCTION</scope>
    <scope>CATALYTIC ACTIVITY</scope>
    <scope>SUBCELLULAR LOCATION</scope>
    <scope>MUTAGENESIS OF ARG-77; MET-100; TRP-176; VAL-218; ASP-239 AND 750-ARG--ALA-763</scope>
    <scope>VARIANT GLN-77</scope>
    <scope>CHARACTERIZATION OF VARIANT GLN-77</scope>
  </reference>
  <reference evidence="27" key="26">
    <citation type="submission" date="2014-12" db="PDB data bank">
      <title>Crystal structure of wild type human AlaRS catalytic domain.</title>
      <authorList>
        <person name="Zhou H."/>
        <person name="Yang X.L."/>
      </authorList>
    </citation>
    <scope>X-RAY CRYSTALLOGRAPHY (1.28 ANGSTROMS) OF 1-455 IN COMPLEX WITH L-ALANINYL-ADENYLATE ANALOG</scope>
  </reference>
  <reference evidence="29" key="27">
    <citation type="journal article" date="2016" name="J. Am. Chem. Soc." volume="138" first="12948" last="12955">
      <title>Evolutionary Gain of Alanine Mischarging to Noncognate tRNAs with a G4:U69 Base Pair.</title>
      <authorList>
        <person name="Sun L."/>
        <person name="Gomes A.C."/>
        <person name="He W."/>
        <person name="Zhou H."/>
        <person name="Wang X."/>
        <person name="Pan D.W."/>
        <person name="Schimmel P."/>
        <person name="Pan T."/>
        <person name="Yang X.L."/>
      </authorList>
      <dbReference type="PubMed" id="27622773"/>
      <dbReference type="DOI" id="10.1021/jacs.6b07121"/>
    </citation>
    <scope>X-RAY CRYSTALLOGRAPHY (2.68 ANGSTROMS) OF 4-453 IN COMPLEX WITH L-ALANINYL-ADENYLATE ANALOG</scope>
    <scope>CATALYTIC ACTIVITY</scope>
    <scope>FUNCTION</scope>
    <scope>MUTAGENESIS OF ALA-448</scope>
  </reference>
  <reference evidence="30 31" key="28">
    <citation type="journal article" date="2016" name="Proc. Natl. Acad. Sci. U.S.A." volume="113" first="14300" last="14305">
      <title>Two crystal structures reveal design for repurposing the C-Ala domain of human AlaRS.</title>
      <authorList>
        <person name="Sun L."/>
        <person name="Song Y."/>
        <person name="Blocquel D."/>
        <person name="Yang X.L."/>
        <person name="Schimmel P."/>
      </authorList>
      <dbReference type="PubMed" id="27911835"/>
      <dbReference type="DOI" id="10.1073/pnas.1617316113"/>
    </citation>
    <scope>X-RAY CRYSTALLOGRAPHY (2.00 ANGSTROMS) OF 757-965</scope>
    <scope>CATALYTIC ACTIVITY</scope>
    <scope>FUNCTION</scope>
    <scope>DOMAIN</scope>
    <scope>SUBUNIT</scope>
    <scope>SUBCELLULAR LOCATION</scope>
  </reference>
  <reference evidence="32" key="29">
    <citation type="journal article" date="2017" name="Nat. Commun." volume="8" first="2281" last="2281">
      <title>Double mimicry evades tRNA synthetase editing by toxic vegetable-sourced non-proteinogenic amino acid.</title>
      <authorList>
        <person name="Song Y."/>
        <person name="Zhou H."/>
        <person name="Vo M.N."/>
        <person name="Shi Y."/>
        <person name="Nawaz M.H."/>
        <person name="Vargas-Rodriguez O."/>
        <person name="Diedrich J.K."/>
        <person name="Yates J.R."/>
        <person name="Kishi S."/>
        <person name="Musier-Forsyth K."/>
        <person name="Schimmel P."/>
      </authorList>
      <dbReference type="PubMed" id="29273753"/>
      <dbReference type="DOI" id="10.1038/s41467-017-02201-z"/>
    </citation>
    <scope>X-RAY CRYSTALLOGRAPHY (2.03 ANGSTROMS) OF 1-455 IN COMPLEX WITH AZETIDINE-2-CARBOXYLIC ACID</scope>
  </reference>
  <reference key="30">
    <citation type="journal article" date="2020" name="J. Biol. Chem." volume="295" first="11822" last="11832">
      <title>Methyltransferase-like 21C (METTL21C) methylates alanine tRNA synthetase at Lys-943 in muscle tissue.</title>
      <authorList>
        <person name="Zoabi M."/>
        <person name="Zhang L."/>
        <person name="Li T.M."/>
        <person name="Elias J.E."/>
        <person name="Carlson S.M."/>
        <person name="Gozani O."/>
      </authorList>
      <dbReference type="PubMed" id="32611769"/>
      <dbReference type="DOI" id="10.1074/jbc.ra120.014505"/>
    </citation>
    <scope>METHYLATION AT LYS-943</scope>
    <scope>MUTAGENESIS OF LYS-943</scope>
  </reference>
  <reference key="31">
    <citation type="journal article" date="2010" name="Am. J. Hum. Genet." volume="86" first="77" last="82">
      <title>A major determinant for binding and aminoacylation of tRNA(Ala) in cytoplasmic Alanyl-tRNA synthetase is mutated in dominant axonal Charcot-Marie-Tooth disease.</title>
      <authorList>
        <person name="Latour P."/>
        <person name="Thauvin-Robinet C."/>
        <person name="Baudelet-Mery C."/>
        <person name="Soichot P."/>
        <person name="Cusin V."/>
        <person name="Faivre L."/>
        <person name="Locatelli M.C."/>
        <person name="Mayencon M."/>
        <person name="Sarcey A."/>
        <person name="Broussolle E."/>
        <person name="Camu W."/>
        <person name="David A."/>
        <person name="Rousson R."/>
      </authorList>
      <dbReference type="PubMed" id="20045102"/>
      <dbReference type="DOI" id="10.1016/j.ajhg.2009.12.005"/>
    </citation>
    <scope>VARIANT CMT2N HIS-329</scope>
  </reference>
  <reference key="32">
    <citation type="journal article" date="2011" name="PLoS ONE" volume="6" first="E29393" last="E29393">
      <title>The mutational spectrum in a cohort of Charcot-Marie-Tooth disease type 2 among the Han Chinese in Taiwan.</title>
      <authorList>
        <person name="Lin K.P."/>
        <person name="Soong B.W."/>
        <person name="Yang C.C."/>
        <person name="Huang L.W."/>
        <person name="Chang M.H."/>
        <person name="Lee I.H."/>
        <person name="Antonellis A."/>
        <person name="Lee Y.C."/>
      </authorList>
      <dbReference type="PubMed" id="22206013"/>
      <dbReference type="DOI" id="10.1371/journal.pone.0029393"/>
    </citation>
    <scope>VARIANT CMT2N TYR-71</scope>
  </reference>
  <reference key="33">
    <citation type="journal article" date="2012" name="Hum. Mutat." volume="33" first="244" last="253">
      <title>A recurrent loss-of-function alanyl-tRNA synthetase (AARS) mutation in patients with Charcot-Marie-Tooth disease type 2N (CMT2N).</title>
      <authorList>
        <person name="McLaughlin H.M."/>
        <person name="Sakaguchi R."/>
        <person name="Giblin W."/>
        <person name="Wilson T.E."/>
        <person name="Biesecker L."/>
        <person name="Lupski J.R."/>
        <person name="Talbot K."/>
        <person name="Vance J.M."/>
        <person name="Zuchner S."/>
        <person name="Lee Y.C."/>
        <person name="Kennerson M."/>
        <person name="Hou Y.M."/>
        <person name="Nicholson G."/>
        <person name="Antonellis A."/>
      </authorList>
      <dbReference type="PubMed" id="22009580"/>
      <dbReference type="DOI" id="10.1002/humu.21635"/>
    </citation>
    <scope>VARIANT CMT2N HIS-329</scope>
    <scope>CHARACTERIZATION OF VARIANT CMT2N HIS-329</scope>
  </reference>
  <reference key="34">
    <citation type="journal article" date="2014" name="J. Neurol." volume="261" first="970" last="982">
      <title>Whole-exome sequencing in patients with inherited neuropathies: outcome and challenges.</title>
      <authorList>
        <person name="Schabhuettl M."/>
        <person name="Wieland T."/>
        <person name="Senderek J."/>
        <person name="Baets J."/>
        <person name="Timmerman V."/>
        <person name="De Jonghe P."/>
        <person name="Reilly M.M."/>
        <person name="Stieglbauer K."/>
        <person name="Laich E."/>
        <person name="Windhager R."/>
        <person name="Erwa W."/>
        <person name="Trajanoski S."/>
        <person name="Strom T.M."/>
        <person name="Auer-Grumbach M."/>
      </authorList>
      <dbReference type="PubMed" id="24627108"/>
      <dbReference type="DOI" id="10.1007/s00415-014-7289-8"/>
    </citation>
    <scope>VARIANT MET-608</scope>
  </reference>
  <reference key="35">
    <citation type="journal article" date="2017" name="Hum. Mutat." volume="38" first="1348" last="1354">
      <title>Deficient activity of alanyl-tRNA synthetase underlies an autosomal recessive syndrome of progressive microcephaly, hypomyelination, and epileptic encephalopathy.</title>
      <authorList>
        <person name="Nakayama T."/>
        <person name="Wu J."/>
        <person name="Galvin-Parton P."/>
        <person name="Weiss J."/>
        <person name="Andriola M.R."/>
        <person name="Hill R.S."/>
        <person name="Vaughan D.J."/>
        <person name="El-Quessny M."/>
        <person name="Barry B.J."/>
        <person name="Partlow J.N."/>
        <person name="Barkovich A.J."/>
        <person name="Ling J."/>
        <person name="Mochida G.H."/>
      </authorList>
      <dbReference type="PubMed" id="28493438"/>
      <dbReference type="DOI" id="10.1002/humu.23250"/>
    </citation>
    <scope>VARIANT DEE29 ASP-913</scope>
    <scope>CHARACTERIZATION OF VARIANT DEE29 ASP-913</scope>
    <scope>FUNCTION</scope>
    <scope>CATALYTIC ACTIVITY</scope>
    <scope>MUTAGENESIS OF CYS-723</scope>
  </reference>
  <reference key="36">
    <citation type="journal article" date="2022" name="BMC Neurol." volume="22" first="299" last="299">
      <title>Clinical characteristics and proteome modifications in two Charcot-Marie-Tooth families with the AARS1 Arg326Trp mutation.</title>
      <authorList>
        <person name="Hoeyer H."/>
        <person name="Busk O.L."/>
        <person name="Esbensen Q.Y."/>
        <person name="Roesby O."/>
        <person name="Hilmarsen H.T."/>
        <person name="Russell M.B."/>
        <person name="Nyman T.A."/>
        <person name="Braathen G.J."/>
        <person name="Nilsen H.L."/>
      </authorList>
      <dbReference type="PubMed" id="35971119"/>
      <dbReference type="DOI" id="10.1186/s12883-022-02828-6"/>
    </citation>
    <scope>VARIANT CMT2N TRP-326</scope>
  </reference>
  <reference key="37">
    <citation type="journal article" date="2022" name="Front. Pediatr." volume="10" first="935721" last="935721">
      <title>Case Report: Early-Onset Charcot-Marie-Tooth 2N With Reversible White Matter Lesions Repeatedly Mimicked Stroke or Encephalitis.</title>
      <authorList>
        <person name="Huang H."/>
        <person name="Zhang Y."/>
        <person name="Yang M."/>
        <person name="Lian B."/>
        <person name="Guo R."/>
        <person name="Cao L."/>
      </authorList>
      <dbReference type="PubMed" id="35911843"/>
      <dbReference type="DOI" id="10.3389/fped.2022.935721"/>
    </citation>
    <scope>VARIANT CMT2N PHE-698</scope>
  </reference>
  <reference key="38">
    <citation type="journal article" date="2023" name="Transl. Neurodegener." volume="12" first="19" last="19">
      <title>An AARS1 variant identified to cause adult-onset leukoencephalopathy with neuroaxonal spheroids and pigmented glia.</title>
      <authorList>
        <person name="Wu J."/>
        <person name="Liu T."/>
        <person name="Zhang B."/>
        <person name="Liu C."/>
        <person name="Luan X."/>
        <person name="Cao L."/>
      </authorList>
      <dbReference type="PubMed" id="37106376"/>
      <dbReference type="DOI" id="10.1186/s40035-023-00353-1"/>
    </citation>
    <scope>VARIANT HDLS2 ILE-606</scope>
  </reference>
  <comment type="function">
    <text evidence="9 10 11 12 15 19 20">Catalyzes the attachment of alanine to tRNA(Ala) in a two-step reaction: alanine is first activated by ATP to form Ala-AMP and then transferred to the acceptor end of tRNA(Ala) (PubMed:27622773, PubMed:27911835, PubMed:28493438, PubMed:33909043). Also edits incorrectly charged tRNA(Ala) via its editing domain (PubMed:27622773, PubMed:27911835, PubMed:28493438, PubMed:29273753). In presence of high levels of lactate, also acts as a protein lactyltransferase that mediates lactylation of lysine residues in target proteins, such as TEAD1, TP53/p53 and YAP1 (PubMed:38512451, PubMed:38653238). Protein lactylation takes place in a two-step reaction: lactate is first activated by ATP to form lactate-AMP and then transferred to lysine residues of target proteins (PubMed:38512451, PubMed:38653238). Acts as an inhibitor of TP53/p53 activity by catalyzing lactylation of TP53/p53 (PubMed:38653238). Acts as a positive regulator of the Hippo pathway by mediating lactylation of TEAD1 and YAP1 (PubMed:38512451).</text>
  </comment>
  <comment type="catalytic activity">
    <reaction evidence="1 8 9 10 11">
      <text>ATP + L-alanine + tRNA(Ala) = AMP + diphosphate + L-alanyl-tRNA(Ala)</text>
      <dbReference type="Rhea" id="RHEA:12540"/>
      <dbReference type="Rhea" id="RHEA-COMP:9657"/>
      <dbReference type="Rhea" id="RHEA-COMP:9923"/>
      <dbReference type="ChEBI" id="CHEBI:30616"/>
      <dbReference type="ChEBI" id="CHEBI:33019"/>
      <dbReference type="ChEBI" id="CHEBI:57972"/>
      <dbReference type="ChEBI" id="CHEBI:78442"/>
      <dbReference type="ChEBI" id="CHEBI:78497"/>
      <dbReference type="ChEBI" id="CHEBI:456215"/>
      <dbReference type="EC" id="6.1.1.7"/>
    </reaction>
  </comment>
  <comment type="catalytic activity">
    <reaction evidence="19 20">
      <text>(S)-lactate + ATP + H(+) = (S)-lactoyl-AMP + diphosphate</text>
      <dbReference type="Rhea" id="RHEA:80271"/>
      <dbReference type="ChEBI" id="CHEBI:15378"/>
      <dbReference type="ChEBI" id="CHEBI:16651"/>
      <dbReference type="ChEBI" id="CHEBI:30616"/>
      <dbReference type="ChEBI" id="CHEBI:33019"/>
      <dbReference type="ChEBI" id="CHEBI:231470"/>
    </reaction>
    <physiologicalReaction direction="left-to-right" evidence="19 20">
      <dbReference type="Rhea" id="RHEA:80272"/>
    </physiologicalReaction>
  </comment>
  <comment type="catalytic activity">
    <reaction evidence="19 20">
      <text>(S)-lactoyl-AMP + L-lysyl-[protein] = AMP + 2 H(+) + N(6)-[(S)-lactoyl]-L-lysyl-[protein]</text>
      <dbReference type="Rhea" id="RHEA:80275"/>
      <dbReference type="Rhea" id="RHEA-COMP:9752"/>
      <dbReference type="Rhea" id="RHEA-COMP:19466"/>
      <dbReference type="ChEBI" id="CHEBI:15378"/>
      <dbReference type="ChEBI" id="CHEBI:29969"/>
      <dbReference type="ChEBI" id="CHEBI:231470"/>
      <dbReference type="ChEBI" id="CHEBI:231527"/>
      <dbReference type="ChEBI" id="CHEBI:456215"/>
    </reaction>
    <physiologicalReaction direction="left-to-right" evidence="19 20">
      <dbReference type="Rhea" id="RHEA:80276"/>
    </physiologicalReaction>
  </comment>
  <comment type="cofactor">
    <cofactor evidence="1">
      <name>Zn(2+)</name>
      <dbReference type="ChEBI" id="CHEBI:29105"/>
    </cofactor>
    <text evidence="1">Binds 1 zinc ion per subunit.</text>
  </comment>
  <comment type="activity regulation">
    <text evidence="20">The protein lactyltransferase activity is inhibited by beta-alanine.</text>
  </comment>
  <comment type="biophysicochemical properties">
    <kinetics>
      <KM evidence="8">3.1 uM for tRNA(Ala) (at 37 Celsius)</KM>
      <text evidence="8">kcat is 0.4 sec(-1).</text>
    </kinetics>
  </comment>
  <comment type="subunit">
    <text evidence="1 10">Monomer (PubMed:27911835). Interacts with ANKRD16; the interaction is direct (By similarity).</text>
  </comment>
  <comment type="subcellular location">
    <subcellularLocation>
      <location evidence="1 10 19">Cytoplasm</location>
    </subcellularLocation>
    <subcellularLocation>
      <location evidence="19">Nucleus</location>
    </subcellularLocation>
    <text evidence="19">Translocates to the nucleus in response to increased levels of lactate; nuclear translocation is dependent on KPNA4.</text>
  </comment>
  <comment type="alternative products">
    <event type="alternative splicing"/>
    <isoform>
      <id>P49588-1</id>
      <name>1</name>
      <sequence type="displayed"/>
    </isoform>
    <isoform>
      <id>P49588-2</id>
      <name>2</name>
      <sequence type="described" ref="VSP_057201 VSP_057202"/>
    </isoform>
  </comment>
  <comment type="domain">
    <text evidence="1">Consists of three domains; the N-terminal catalytic domain, the editing domain and the C-terminal C-Ala domain. The editing domain removes incorrectly charged amino acids, while the C-Ala domain, along with tRNA(Ala), serves as a bridge to cooperatively bring together the editing and aminoacylation centers thus stimulating deacylation of misacylated tRNAs.</text>
  </comment>
  <comment type="domain">
    <text evidence="3 10">The C-terminal C-Ala domain (residues 756 to 968) is not required for catalytic activity and can bind DNA (in vitro) (PubMed:27911835). The C-terminal C-Ala domain (residues 756 to 968), along with tRNA(Ala), serves as a bridge to cooperatively bring together the editing and aminoacylation centers thus stimulating deacylation of misacylated tRNAs. The human domain can be used in vitro to replace the corresponding domain in E.coli (PubMed:19661429).</text>
  </comment>
  <comment type="PTM">
    <text evidence="1 2">ISGylated.</text>
  </comment>
  <comment type="PTM">
    <text evidence="14">Methylation at 'Lys-943' by METTL21C.</text>
  </comment>
  <comment type="disease" evidence="4 5 6 16 17">
    <disease id="DI-02678">
      <name>Charcot-Marie-Tooth disease, axonal, 2N</name>
      <acronym>CMT2N</acronym>
      <description>An axonal form of Charcot-Marie-Tooth disease, a disorder of the peripheral nervous system, characterized by progressive weakness and atrophy, initially of the peroneal muscles and later of the distal muscles of the arms. Charcot-Marie-Tooth disease is classified in two main groups on the basis of electrophysiologic properties and histopathology: primary peripheral demyelinating neuropathies (designated CMT1 when they are dominantly inherited) and primary peripheral axonal neuropathies (CMT2). Neuropathies of the CMT2 group are characterized by signs of axonal degeneration in the absence of obvious myelin alterations, normal or slightly reduced nerve conduction velocities, and progressive distal muscle weakness and atrophy.</description>
      <dbReference type="MIM" id="613287"/>
    </disease>
    <text>The disease is caused by variants affecting the gene represented in this entry.</text>
  </comment>
  <comment type="disease" evidence="8 11">
    <disease id="DI-04412">
      <name>Developmental and epileptic encephalopathy 29</name>
      <acronym>DEE29</acronym>
      <description>A form of epileptic encephalopathy, a heterogeneous group of severe early-onset epilepsies characterized by refractory seizures, neurodevelopmental impairment, and poor prognosis. Development is normal prior to seizure onset, after which cognitive and motor delays become apparent. DEE29 patients manifest severe infantile epileptic encephalopathy, clubfoot, absent deep tendon reflexes, extrapyramidal symptoms, and persistently deficient myelination.</description>
      <dbReference type="MIM" id="616339"/>
    </disease>
    <text>The disease is caused by variants affecting the gene represented in this entry.</text>
  </comment>
  <comment type="disease" evidence="13 18">
    <disease id="DI-06298">
      <name>Leukoencephalopathy, hereditary diffuse, with spheroids 2</name>
      <acronym>HDLS2</acronym>
      <description>An autosomal dominant neurodegenerative disorder characterized by progressive cognitive and executive dysfunction, psychiatric disturbances, and neurologic symptoms, such as gait abnormalities, paresis, seizures, and rigidity. Symptom onset is usually in adulthood, although earlier onset has been reported. Some patients have an acute encephalopathic course with severe neurologic decline resulting in early death, whereas other patients have a more protracted and chronic disease course. Neuropathologic examination shows a leukoencephalopathy with axonal spheroids and myelination defects.</description>
      <dbReference type="MIM" id="619661"/>
    </disease>
    <text>The disease may be caused by variants affecting the gene represented in this entry.</text>
  </comment>
  <comment type="disease" evidence="15">
    <disease id="DI-06299">
      <name>Trichothiodystrophy 8, non-photosensitive</name>
      <acronym>TTD8</acronym>
      <description>A form of trichothiodystrophy, a disease characterized by sulfur-deficient brittle hair and multisystem variable abnormalities. The spectrum of clinical features varies from mild disease with only hair involvement to severe disease with cutaneous, neurologic and profound developmental defects. Ichthyosis, intellectual and developmental disabilities, decreased fertility, abnormal characteristics at birth, ocular abnormalities, short stature, and infections are common manifestations. There are both photosensitive and non-photosensitive forms of the disorder. TTD8 is an autosomal recessive, non-photosensitive form characterized by brittle hair and nails, scaly skin, accompanied by failure to thrive, microcephaly, and neuromotor developmental delay.</description>
      <dbReference type="MIM" id="619691"/>
    </disease>
    <text>The disease may be caused by variants affecting the gene represented in this entry.</text>
  </comment>
  <comment type="similarity">
    <text evidence="1">Belongs to the class-II aminoacyl-tRNA synthetase family.</text>
  </comment>
  <dbReference type="EC" id="6.1.1.7" evidence="1 8 9 10 11"/>
  <dbReference type="EC" id="6.-.-.-" evidence="19 20"/>
  <dbReference type="EMBL" id="D32050">
    <property type="protein sequence ID" value="BAA06808.1"/>
    <property type="molecule type" value="mRNA"/>
  </dbReference>
  <dbReference type="EMBL" id="AK299098">
    <property type="protein sequence ID" value="BAG61157.1"/>
    <property type="molecule type" value="mRNA"/>
  </dbReference>
  <dbReference type="EMBL" id="AK222824">
    <property type="protein sequence ID" value="BAD96544.1"/>
    <property type="molecule type" value="mRNA"/>
  </dbReference>
  <dbReference type="EMBL" id="AC012184">
    <property type="status" value="NOT_ANNOTATED_CDS"/>
    <property type="molecule type" value="Genomic_DNA"/>
  </dbReference>
  <dbReference type="EMBL" id="CH471241">
    <property type="protein sequence ID" value="EAW51839.1"/>
    <property type="molecule type" value="Genomic_DNA"/>
  </dbReference>
  <dbReference type="EMBL" id="BC011451">
    <property type="protein sequence ID" value="AAH11451.1"/>
    <property type="molecule type" value="mRNA"/>
  </dbReference>
  <dbReference type="CCDS" id="CCDS32474.1">
    <molecule id="P49588-1"/>
  </dbReference>
  <dbReference type="PIR" id="I60107">
    <property type="entry name" value="I60107"/>
  </dbReference>
  <dbReference type="RefSeq" id="NP_001596.2">
    <molecule id="P49588-1"/>
    <property type="nucleotide sequence ID" value="NM_001605.2"/>
  </dbReference>
  <dbReference type="PDB" id="4XEM">
    <property type="method" value="X-ray"/>
    <property type="resolution" value="1.28 A"/>
    <property type="chains" value="A=1-455"/>
  </dbReference>
  <dbReference type="PDB" id="4XEO">
    <property type="method" value="X-ray"/>
    <property type="resolution" value="1.38 A"/>
    <property type="chains" value="A/B=1-455"/>
  </dbReference>
  <dbReference type="PDB" id="5KNN">
    <property type="method" value="X-ray"/>
    <property type="resolution" value="2.68 A"/>
    <property type="chains" value="A/B/C/D/E/F/G/H=4-453"/>
  </dbReference>
  <dbReference type="PDB" id="5T5S">
    <property type="method" value="X-ray"/>
    <property type="resolution" value="2.20 A"/>
    <property type="chains" value="A=757-965"/>
  </dbReference>
  <dbReference type="PDB" id="5T76">
    <property type="method" value="X-ray"/>
    <property type="resolution" value="2.00 A"/>
    <property type="chains" value="A=757-965"/>
  </dbReference>
  <dbReference type="PDB" id="5V59">
    <property type="method" value="X-ray"/>
    <property type="resolution" value="2.03 A"/>
    <property type="chains" value="A=1-455"/>
  </dbReference>
  <dbReference type="PDBsum" id="4XEM"/>
  <dbReference type="PDBsum" id="4XEO"/>
  <dbReference type="PDBsum" id="5KNN"/>
  <dbReference type="PDBsum" id="5T5S"/>
  <dbReference type="PDBsum" id="5T76"/>
  <dbReference type="PDBsum" id="5V59"/>
  <dbReference type="AlphaFoldDB" id="P49588"/>
  <dbReference type="SMR" id="P49588"/>
  <dbReference type="BioGRID" id="106534">
    <property type="interactions" value="177"/>
  </dbReference>
  <dbReference type="IntAct" id="P49588">
    <property type="interactions" value="31"/>
  </dbReference>
  <dbReference type="MINT" id="P49588"/>
  <dbReference type="STRING" id="9606.ENSP00000261772"/>
  <dbReference type="BindingDB" id="P49588"/>
  <dbReference type="ChEMBL" id="CHEMBL3574"/>
  <dbReference type="DrugBank" id="DB00160">
    <property type="generic name" value="Alanine"/>
  </dbReference>
  <dbReference type="GlyGen" id="P49588">
    <property type="glycosylation" value="1 site, 1 O-linked glycan (1 site)"/>
  </dbReference>
  <dbReference type="iPTMnet" id="P49588"/>
  <dbReference type="MetOSite" id="P49588"/>
  <dbReference type="PhosphoSitePlus" id="P49588"/>
  <dbReference type="SwissPalm" id="P49588"/>
  <dbReference type="BioMuta" id="AARS"/>
  <dbReference type="DMDM" id="115502460"/>
  <dbReference type="CPTAC" id="CPTAC-1"/>
  <dbReference type="CPTAC" id="CPTAC-2"/>
  <dbReference type="jPOST" id="P49588"/>
  <dbReference type="MassIVE" id="P49588"/>
  <dbReference type="PaxDb" id="9606-ENSP00000261772"/>
  <dbReference type="PeptideAtlas" id="P49588"/>
  <dbReference type="ProteomicsDB" id="56022">
    <molecule id="P49588-1"/>
  </dbReference>
  <dbReference type="Pumba" id="P49588"/>
  <dbReference type="ABCD" id="P49588">
    <property type="antibodies" value="3 sequenced antibodies"/>
  </dbReference>
  <dbReference type="Antibodypedia" id="29958">
    <property type="antibodies" value="259 antibodies from 29 providers"/>
  </dbReference>
  <dbReference type="DNASU" id="16"/>
  <dbReference type="Ensembl" id="ENST00000261772.13">
    <molecule id="P49588-1"/>
    <property type="protein sequence ID" value="ENSP00000261772.8"/>
    <property type="gene ID" value="ENSG00000090861.17"/>
  </dbReference>
  <dbReference type="Ensembl" id="ENST00000674691.1">
    <molecule id="P49588-1"/>
    <property type="protein sequence ID" value="ENSP00000502247.1"/>
    <property type="gene ID" value="ENSG00000090861.17"/>
  </dbReference>
  <dbReference type="Ensembl" id="ENST00000674963.1">
    <molecule id="P49588-1"/>
    <property type="protein sequence ID" value="ENSP00000501924.1"/>
    <property type="gene ID" value="ENSG00000090861.17"/>
  </dbReference>
  <dbReference type="Ensembl" id="ENST00000675643.1">
    <molecule id="P49588-1"/>
    <property type="protein sequence ID" value="ENSP00000502797.1"/>
    <property type="gene ID" value="ENSG00000090861.17"/>
  </dbReference>
  <dbReference type="GeneID" id="16"/>
  <dbReference type="KEGG" id="hsa:16"/>
  <dbReference type="MANE-Select" id="ENST00000261772.13">
    <property type="protein sequence ID" value="ENSP00000261772.8"/>
    <property type="RefSeq nucleotide sequence ID" value="NM_001605.3"/>
    <property type="RefSeq protein sequence ID" value="NP_001596.2"/>
  </dbReference>
  <dbReference type="UCSC" id="uc002eyn.2">
    <molecule id="P49588-1"/>
    <property type="organism name" value="human"/>
  </dbReference>
  <dbReference type="AGR" id="HGNC:20"/>
  <dbReference type="CTD" id="16"/>
  <dbReference type="DisGeNET" id="16"/>
  <dbReference type="GeneCards" id="AARS1"/>
  <dbReference type="GeneReviews" id="AARS1"/>
  <dbReference type="HGNC" id="HGNC:20">
    <property type="gene designation" value="AARS1"/>
  </dbReference>
  <dbReference type="HPA" id="ENSG00000090861">
    <property type="expression patterns" value="Low tissue specificity"/>
  </dbReference>
  <dbReference type="MalaCards" id="AARS1"/>
  <dbReference type="MIM" id="601065">
    <property type="type" value="gene"/>
  </dbReference>
  <dbReference type="MIM" id="613287">
    <property type="type" value="phenotype"/>
  </dbReference>
  <dbReference type="MIM" id="616339">
    <property type="type" value="phenotype"/>
  </dbReference>
  <dbReference type="MIM" id="619661">
    <property type="type" value="phenotype"/>
  </dbReference>
  <dbReference type="MIM" id="619691">
    <property type="type" value="phenotype"/>
  </dbReference>
  <dbReference type="neXtProt" id="NX_P49588"/>
  <dbReference type="OpenTargets" id="ENSG00000090861"/>
  <dbReference type="Orphanet" id="228174">
    <property type="disease" value="Autosomal dominant Charcot-Marie-Tooth disease type 2N"/>
  </dbReference>
  <dbReference type="Orphanet" id="442835">
    <property type="disease" value="Non-specific early-onset epileptic encephalopathy"/>
  </dbReference>
  <dbReference type="Orphanet" id="33364">
    <property type="disease" value="Trichothiodystrophy"/>
  </dbReference>
  <dbReference type="PharmGKB" id="PA24367"/>
  <dbReference type="VEuPathDB" id="HostDB:ENSG00000090861"/>
  <dbReference type="eggNOG" id="KOG0188">
    <property type="taxonomic scope" value="Eukaryota"/>
  </dbReference>
  <dbReference type="GeneTree" id="ENSGT00940000157335"/>
  <dbReference type="HOGENOM" id="CLU_004485_5_0_1"/>
  <dbReference type="InParanoid" id="P49588"/>
  <dbReference type="OMA" id="DTYHHTM"/>
  <dbReference type="OrthoDB" id="3639120at2759"/>
  <dbReference type="PhylomeDB" id="P49588"/>
  <dbReference type="TreeFam" id="TF300737"/>
  <dbReference type="PathwayCommons" id="P49588"/>
  <dbReference type="Reactome" id="R-HSA-379716">
    <property type="pathway name" value="Cytosolic tRNA aminoacylation"/>
  </dbReference>
  <dbReference type="SignaLink" id="P49588"/>
  <dbReference type="SIGNOR" id="P49588"/>
  <dbReference type="BioGRID-ORCS" id="16">
    <property type="hits" value="818 hits in 1135 CRISPR screens"/>
  </dbReference>
  <dbReference type="ChiTaRS" id="AARS">
    <property type="organism name" value="human"/>
  </dbReference>
  <dbReference type="GenomeRNAi" id="16"/>
  <dbReference type="Pharos" id="P49588">
    <property type="development level" value="Tbio"/>
  </dbReference>
  <dbReference type="PRO" id="PR:P49588"/>
  <dbReference type="Proteomes" id="UP000005640">
    <property type="component" value="Chromosome 16"/>
  </dbReference>
  <dbReference type="RNAct" id="P49588">
    <property type="molecule type" value="protein"/>
  </dbReference>
  <dbReference type="Bgee" id="ENSG00000090861">
    <property type="expression patterns" value="Expressed in endometrium epithelium and 213 other cell types or tissues"/>
  </dbReference>
  <dbReference type="ExpressionAtlas" id="P49588">
    <property type="expression patterns" value="baseline and differential"/>
  </dbReference>
  <dbReference type="GO" id="GO:0005737">
    <property type="term" value="C:cytoplasm"/>
    <property type="evidence" value="ECO:0000304"/>
    <property type="project" value="ProtInc"/>
  </dbReference>
  <dbReference type="GO" id="GO:0005829">
    <property type="term" value="C:cytosol"/>
    <property type="evidence" value="ECO:0000314"/>
    <property type="project" value="HPA"/>
  </dbReference>
  <dbReference type="GO" id="GO:0070062">
    <property type="term" value="C:extracellular exosome"/>
    <property type="evidence" value="ECO:0007005"/>
    <property type="project" value="UniProtKB"/>
  </dbReference>
  <dbReference type="GO" id="GO:0016020">
    <property type="term" value="C:membrane"/>
    <property type="evidence" value="ECO:0007005"/>
    <property type="project" value="UniProtKB"/>
  </dbReference>
  <dbReference type="GO" id="GO:0005739">
    <property type="term" value="C:mitochondrion"/>
    <property type="evidence" value="ECO:0000318"/>
    <property type="project" value="GO_Central"/>
  </dbReference>
  <dbReference type="GO" id="GO:0004813">
    <property type="term" value="F:alanine-tRNA ligase activity"/>
    <property type="evidence" value="ECO:0000314"/>
    <property type="project" value="UniProtKB"/>
  </dbReference>
  <dbReference type="GO" id="GO:0016597">
    <property type="term" value="F:amino acid binding"/>
    <property type="evidence" value="ECO:0007669"/>
    <property type="project" value="Ensembl"/>
  </dbReference>
  <dbReference type="GO" id="GO:0002161">
    <property type="term" value="F:aminoacyl-tRNA editing activity"/>
    <property type="evidence" value="ECO:0000314"/>
    <property type="project" value="UniProtKB"/>
  </dbReference>
  <dbReference type="GO" id="GO:0005524">
    <property type="term" value="F:ATP binding"/>
    <property type="evidence" value="ECO:0007669"/>
    <property type="project" value="UniProtKB-UniRule"/>
  </dbReference>
  <dbReference type="GO" id="GO:0002196">
    <property type="term" value="F:Ser-tRNA(Ala) hydrolase activity"/>
    <property type="evidence" value="ECO:0000250"/>
    <property type="project" value="UniProtKB"/>
  </dbReference>
  <dbReference type="GO" id="GO:0000049">
    <property type="term" value="F:tRNA binding"/>
    <property type="evidence" value="ECO:0000304"/>
    <property type="project" value="ProtInc"/>
  </dbReference>
  <dbReference type="GO" id="GO:0008270">
    <property type="term" value="F:zinc ion binding"/>
    <property type="evidence" value="ECO:0007669"/>
    <property type="project" value="UniProtKB-UniRule"/>
  </dbReference>
  <dbReference type="GO" id="GO:0006419">
    <property type="term" value="P:alanyl-tRNA aminoacylation"/>
    <property type="evidence" value="ECO:0000314"/>
    <property type="project" value="UniProtKB"/>
  </dbReference>
  <dbReference type="GO" id="GO:0021680">
    <property type="term" value="P:cerebellar Purkinje cell layer development"/>
    <property type="evidence" value="ECO:0007669"/>
    <property type="project" value="Ensembl"/>
  </dbReference>
  <dbReference type="GO" id="GO:0043524">
    <property type="term" value="P:negative regulation of neuron apoptotic process"/>
    <property type="evidence" value="ECO:0007669"/>
    <property type="project" value="Ensembl"/>
  </dbReference>
  <dbReference type="GO" id="GO:0050885">
    <property type="term" value="P:neuromuscular process controlling balance"/>
    <property type="evidence" value="ECO:0007669"/>
    <property type="project" value="Ensembl"/>
  </dbReference>
  <dbReference type="GO" id="GO:0051402">
    <property type="term" value="P:neuron apoptotic process"/>
    <property type="evidence" value="ECO:0007669"/>
    <property type="project" value="Ensembl"/>
  </dbReference>
  <dbReference type="GO" id="GO:0140018">
    <property type="term" value="P:regulation of cytoplasmic translational fidelity"/>
    <property type="evidence" value="ECO:0007669"/>
    <property type="project" value="Ensembl"/>
  </dbReference>
  <dbReference type="GO" id="GO:0006418">
    <property type="term" value="P:tRNA aminoacylation for protein translation"/>
    <property type="evidence" value="ECO:0000304"/>
    <property type="project" value="Reactome"/>
  </dbReference>
  <dbReference type="GO" id="GO:0006400">
    <property type="term" value="P:tRNA modification"/>
    <property type="evidence" value="ECO:0000250"/>
    <property type="project" value="UniProtKB"/>
  </dbReference>
  <dbReference type="GO" id="GO:0008033">
    <property type="term" value="P:tRNA processing"/>
    <property type="evidence" value="ECO:0000304"/>
    <property type="project" value="ProtInc"/>
  </dbReference>
  <dbReference type="CDD" id="cd00673">
    <property type="entry name" value="AlaRS_core"/>
    <property type="match status" value="1"/>
  </dbReference>
  <dbReference type="Gene3D" id="2.40.30.130">
    <property type="match status" value="1"/>
  </dbReference>
  <dbReference type="Gene3D" id="3.10.310.40">
    <property type="match status" value="1"/>
  </dbReference>
  <dbReference type="HAMAP" id="MF_00036_B">
    <property type="entry name" value="Ala_tRNA_synth_B"/>
    <property type="match status" value="1"/>
  </dbReference>
  <dbReference type="InterPro" id="IPR045864">
    <property type="entry name" value="aa-tRNA-synth_II/BPL/LPL"/>
  </dbReference>
  <dbReference type="InterPro" id="IPR002318">
    <property type="entry name" value="Ala-tRNA-lgiase_IIc"/>
  </dbReference>
  <dbReference type="InterPro" id="IPR018162">
    <property type="entry name" value="Ala-tRNA-ligase_IIc_anticod-bd"/>
  </dbReference>
  <dbReference type="InterPro" id="IPR018165">
    <property type="entry name" value="Ala-tRNA-synth_IIc_core"/>
  </dbReference>
  <dbReference type="InterPro" id="IPR018164">
    <property type="entry name" value="Ala-tRNA-synth_IIc_N"/>
  </dbReference>
  <dbReference type="InterPro" id="IPR050058">
    <property type="entry name" value="Ala-tRNA_ligase"/>
  </dbReference>
  <dbReference type="InterPro" id="IPR023033">
    <property type="entry name" value="Ala_tRNA_ligase_euk/bac"/>
  </dbReference>
  <dbReference type="InterPro" id="IPR003156">
    <property type="entry name" value="DHHA1_dom"/>
  </dbReference>
  <dbReference type="InterPro" id="IPR018163">
    <property type="entry name" value="Thr/Ala-tRNA-synth_IIc_edit"/>
  </dbReference>
  <dbReference type="InterPro" id="IPR009000">
    <property type="entry name" value="Transl_B-barrel_sf"/>
  </dbReference>
  <dbReference type="InterPro" id="IPR012947">
    <property type="entry name" value="tRNA_SAD"/>
  </dbReference>
  <dbReference type="NCBIfam" id="TIGR00344">
    <property type="entry name" value="alaS"/>
    <property type="match status" value="1"/>
  </dbReference>
  <dbReference type="PANTHER" id="PTHR11777:SF36">
    <property type="entry name" value="ALANINE--TRNA LIGASE, CYTOPLASMIC"/>
    <property type="match status" value="1"/>
  </dbReference>
  <dbReference type="PANTHER" id="PTHR11777">
    <property type="entry name" value="ALANYL-TRNA SYNTHETASE"/>
    <property type="match status" value="1"/>
  </dbReference>
  <dbReference type="Pfam" id="PF02272">
    <property type="entry name" value="DHHA1"/>
    <property type="match status" value="1"/>
  </dbReference>
  <dbReference type="Pfam" id="PF01411">
    <property type="entry name" value="tRNA-synt_2c"/>
    <property type="match status" value="1"/>
  </dbReference>
  <dbReference type="Pfam" id="PF07973">
    <property type="entry name" value="tRNA_SAD"/>
    <property type="match status" value="1"/>
  </dbReference>
  <dbReference type="PRINTS" id="PR00980">
    <property type="entry name" value="TRNASYNTHALA"/>
  </dbReference>
  <dbReference type="SMART" id="SM00863">
    <property type="entry name" value="tRNA_SAD"/>
    <property type="match status" value="1"/>
  </dbReference>
  <dbReference type="SUPFAM" id="SSF55681">
    <property type="entry name" value="Class II aaRS and biotin synthetases"/>
    <property type="match status" value="1"/>
  </dbReference>
  <dbReference type="SUPFAM" id="SSF101353">
    <property type="entry name" value="Putative anticodon-binding domain of alanyl-tRNA synthetase (AlaRS)"/>
    <property type="match status" value="1"/>
  </dbReference>
  <dbReference type="SUPFAM" id="SSF55186">
    <property type="entry name" value="ThrRS/AlaRS common domain"/>
    <property type="match status" value="1"/>
  </dbReference>
  <dbReference type="SUPFAM" id="SSF50447">
    <property type="entry name" value="Translation proteins"/>
    <property type="match status" value="1"/>
  </dbReference>
  <dbReference type="PROSITE" id="PS50860">
    <property type="entry name" value="AA_TRNA_LIGASE_II_ALA"/>
    <property type="match status" value="1"/>
  </dbReference>
  <proteinExistence type="evidence at protein level"/>
  <keyword id="KW-0002">3D-structure</keyword>
  <keyword id="KW-0007">Acetylation</keyword>
  <keyword id="KW-0025">Alternative splicing</keyword>
  <keyword id="KW-0030">Aminoacyl-tRNA synthetase</keyword>
  <keyword id="KW-0067">ATP-binding</keyword>
  <keyword id="KW-0144">Charcot-Marie-Tooth disease</keyword>
  <keyword id="KW-0963">Cytoplasm</keyword>
  <keyword id="KW-0903">Direct protein sequencing</keyword>
  <keyword id="KW-0225">Disease variant</keyword>
  <keyword id="KW-0887">Epilepsy</keyword>
  <keyword id="KW-0436">Ligase</keyword>
  <keyword id="KW-0479">Metal-binding</keyword>
  <keyword id="KW-0488">Methylation</keyword>
  <keyword id="KW-0523">Neurodegeneration</keyword>
  <keyword id="KW-0622">Neuropathy</keyword>
  <keyword id="KW-0547">Nucleotide-binding</keyword>
  <keyword id="KW-0539">Nucleus</keyword>
  <keyword id="KW-0597">Phosphoprotein</keyword>
  <keyword id="KW-0648">Protein biosynthesis</keyword>
  <keyword id="KW-1267">Proteomics identification</keyword>
  <keyword id="KW-1185">Reference proteome</keyword>
  <keyword id="KW-0694">RNA-binding</keyword>
  <keyword id="KW-0820">tRNA-binding</keyword>
  <keyword id="KW-0832">Ubl conjugation</keyword>
  <keyword id="KW-0862">Zinc</keyword>
  <feature type="chain" id="PRO_0000075281" description="Alanine--tRNA ligase, cytoplasmic">
    <location>
      <begin position="1"/>
      <end position="968"/>
    </location>
  </feature>
  <feature type="short sequence motif" description="Nuclear localization signal" evidence="19">
    <location>
      <begin position="750"/>
      <end position="763"/>
    </location>
  </feature>
  <feature type="binding site" evidence="9 21 27 28 29">
    <location>
      <position position="77"/>
    </location>
    <ligand>
      <name>ATP</name>
      <dbReference type="ChEBI" id="CHEBI:30616"/>
    </ligand>
  </feature>
  <feature type="binding site" evidence="9 21 27 28 29">
    <location>
      <position position="95"/>
    </location>
    <ligand>
      <name>ATP</name>
      <dbReference type="ChEBI" id="CHEBI:30616"/>
    </ligand>
  </feature>
  <feature type="binding site" evidence="9 21 27 28 29">
    <location>
      <position position="176"/>
    </location>
    <ligand>
      <name>ATP</name>
      <dbReference type="ChEBI" id="CHEBI:30616"/>
    </ligand>
  </feature>
  <feature type="binding site" evidence="9 21 27 28 29">
    <location>
      <begin position="214"/>
      <end position="216"/>
    </location>
    <ligand>
      <name>ATP</name>
      <dbReference type="ChEBI" id="CHEBI:30616"/>
    </ligand>
  </feature>
  <feature type="binding site" evidence="9 21 27 28 29">
    <location>
      <position position="216"/>
    </location>
    <ligand>
      <name>L-alanine</name>
      <dbReference type="ChEBI" id="CHEBI:57972"/>
    </ligand>
  </feature>
  <feature type="binding site" evidence="9 21 27 28 29">
    <location>
      <position position="239"/>
    </location>
    <ligand>
      <name>L-alanine</name>
      <dbReference type="ChEBI" id="CHEBI:57972"/>
    </ligand>
  </feature>
  <feature type="binding site" evidence="9 21 27 28 29">
    <location>
      <position position="243"/>
    </location>
    <ligand>
      <name>ATP</name>
      <dbReference type="ChEBI" id="CHEBI:30616"/>
    </ligand>
  </feature>
  <feature type="binding site" evidence="1">
    <location>
      <position position="605"/>
    </location>
    <ligand>
      <name>Zn(2+)</name>
      <dbReference type="ChEBI" id="CHEBI:29105"/>
    </ligand>
  </feature>
  <feature type="binding site" evidence="1">
    <location>
      <position position="609"/>
    </location>
    <ligand>
      <name>Zn(2+)</name>
      <dbReference type="ChEBI" id="CHEBI:29105"/>
    </ligand>
  </feature>
  <feature type="binding site" evidence="1">
    <location>
      <position position="723"/>
    </location>
    <ligand>
      <name>Zn(2+)</name>
      <dbReference type="ChEBI" id="CHEBI:29105"/>
    </ligand>
  </feature>
  <feature type="binding site" evidence="1">
    <location>
      <position position="727"/>
    </location>
    <ligand>
      <name>Zn(2+)</name>
      <dbReference type="ChEBI" id="CHEBI:29105"/>
    </ligand>
  </feature>
  <feature type="modified residue" description="N-acetylmethionine" evidence="1 22 34 37 38">
    <location>
      <position position="1"/>
    </location>
  </feature>
  <feature type="modified residue" description="Phosphoserine" evidence="39">
    <location>
      <position position="3"/>
    </location>
  </feature>
  <feature type="modified residue" description="Phosphoserine" evidence="39">
    <location>
      <position position="8"/>
    </location>
  </feature>
  <feature type="modified residue" description="N6-acetyllysine" evidence="35">
    <location>
      <position position="19"/>
    </location>
  </feature>
  <feature type="modified residue" description="Phosphoserine" evidence="36">
    <location>
      <position position="399"/>
    </location>
  </feature>
  <feature type="modified residue" description="Phosphoserine" evidence="33 39">
    <location>
      <position position="555"/>
    </location>
  </feature>
  <feature type="modified residue" description="N6-acetyllysine" evidence="35">
    <location>
      <position position="876"/>
    </location>
  </feature>
  <feature type="modified residue" description="N6,N6,N6-trimethyllysine; alternate" evidence="14">
    <location>
      <position position="943"/>
    </location>
  </feature>
  <feature type="modified residue" description="N6,N6-dimethyllysine; alternate" evidence="14">
    <location>
      <position position="943"/>
    </location>
  </feature>
  <feature type="modified residue" description="N6-methyllysine; alternate" evidence="14">
    <location>
      <position position="943"/>
    </location>
  </feature>
  <feature type="splice variant" id="VSP_057201" description="In isoform 2." evidence="23">
    <original>G</original>
    <variation>GTYLYSFVR</variation>
    <location>
      <position position="160"/>
    </location>
  </feature>
  <feature type="splice variant" id="VSP_057202" description="In isoform 2." evidence="23">
    <original>K</original>
    <variation>KATQGPGSPPLGLISSL</variation>
    <location>
      <position position="869"/>
    </location>
  </feature>
  <feature type="sequence variant" id="VAR_067084" description="In CMT2N; dbSNP:rs387906792." evidence="6">
    <original>N</original>
    <variation>Y</variation>
    <location>
      <position position="71"/>
    </location>
  </feature>
  <feature type="sequence variant" id="VAR_089575" description="In a gastric cancer; somatic mutation; increased protein lactyltransferase activity." evidence="19">
    <original>R</original>
    <variation>Q</variation>
    <location>
      <position position="77"/>
    </location>
  </feature>
  <feature type="sequence variant" id="VAR_073719" description="In DEE29; hypomorphic allele; results in only 2-fold reduction in aminoacylation efficiency; dbSNP:rs786205157." evidence="8">
    <original>K</original>
    <variation>T</variation>
    <location>
      <position position="81"/>
    </location>
  </feature>
  <feature type="sequence variant" id="VAR_086780" description="In HDLS2; uncertain significance." evidence="13">
    <original>C</original>
    <variation>F</variation>
    <location>
      <position position="152"/>
    </location>
  </feature>
  <feature type="sequence variant" id="VAR_028204" description="In dbSNP:rs11537667.">
    <original>G</original>
    <variation>D</variation>
    <location>
      <position position="275"/>
    </location>
  </feature>
  <feature type="sequence variant" id="VAR_089576" description="In CMT2N." evidence="17">
    <original>R</original>
    <variation>W</variation>
    <location>
      <position position="326"/>
    </location>
  </feature>
  <feature type="sequence variant" id="VAR_063527" description="In CMT2N; severely reduces enzyme activity; dbSNP:rs267606621." evidence="4 5">
    <original>R</original>
    <variation>H</variation>
    <location>
      <position position="329"/>
    </location>
  </feature>
  <feature type="sequence variant" id="VAR_089577" description="In HDLS2; likely pathogenic." evidence="18">
    <original>T</original>
    <variation>I</variation>
    <location>
      <position position="606"/>
    </location>
  </feature>
  <feature type="sequence variant" id="VAR_073293" description="Found in a patient with distal hereditary motor neuropathy; uncertain significance." evidence="7">
    <original>T</original>
    <variation>M</variation>
    <location>
      <position position="608"/>
    </location>
  </feature>
  <feature type="sequence variant" id="VAR_089578" description="In CMT2N." evidence="16">
    <original>S</original>
    <variation>F</variation>
    <location>
      <position position="698"/>
    </location>
  </feature>
  <feature type="sequence variant" id="VAR_086781" description="In TTD8; uncertain significance." evidence="15">
    <original>I</original>
    <variation>T</variation>
    <location>
      <position position="699"/>
    </location>
  </feature>
  <feature type="sequence variant" id="VAR_086782" description="In TTD8; uncertain significance." evidence="15">
    <original>T</original>
    <variation>A</variation>
    <location>
      <position position="726"/>
    </location>
  </feature>
  <feature type="sequence variant" id="VAR_073720" description="In DEE29; results in 10-fold reduction in aminoacylation efficiency; dbSNP:rs143370729." evidence="8">
    <original>R</original>
    <variation>G</variation>
    <location>
      <position position="751"/>
    </location>
  </feature>
  <feature type="sequence variant" id="VAR_086783" description="In TTD8; uncertain significance." evidence="15">
    <original>T</original>
    <variation>I</variation>
    <location>
      <position position="756"/>
    </location>
  </feature>
  <feature type="sequence variant" id="VAR_086784" description="In TTD8; uncertain significance." evidence="15">
    <original>C</original>
    <variation>Y</variation>
    <location>
      <position position="901"/>
    </location>
  </feature>
  <feature type="sequence variant" id="VAR_079703" description="In DEE29; decreases protein abundance; decreases aminoacylation activity; no effect on the editing activity; dbSNP:rs369774476." evidence="11">
    <original>G</original>
    <variation>D</variation>
    <location>
      <position position="913"/>
    </location>
  </feature>
  <feature type="mutagenesis site" description="In mutant 5A; abolished binding to lactate and protein lactylation; when associated with A-77, A-216 and 239-A--A-241." evidence="20">
    <original>M</original>
    <variation>A</variation>
    <location>
      <position position="46"/>
    </location>
  </feature>
  <feature type="mutagenesis site" description="In mutant 5A; abolished binding to lactate and protein lactylation; when associated with A-46, A-216 and 239-A--A-241. In mutant 5M; abolished binding to lactate and protein lactylation; when associated with A-100, E-176, D-218 and A-239." evidence="19 20">
    <original>R</original>
    <variation>A</variation>
    <location>
      <position position="77"/>
    </location>
  </feature>
  <feature type="mutagenesis site" description="In mutant 5M; abolished binding to lactate and protein lactylation; when associated with A-77, E-176, D-218 and A-239." evidence="19">
    <original>M</original>
    <variation>A</variation>
    <location>
      <position position="100"/>
    </location>
  </feature>
  <feature type="mutagenesis site" description="In mutant 5M; abolished binding to lactate and protein lactylation; when associated with A-77, A-100, D-218 and A-239." evidence="19">
    <original>W</original>
    <variation>E</variation>
    <location>
      <position position="176"/>
    </location>
  </feature>
  <feature type="mutagenesis site" description="In mutant 5A; abolished binding to lactate and protein lactylation; when associated with A-46, A-77 and 239-A--A-241." evidence="20">
    <original>N</original>
    <variation>A</variation>
    <location>
      <position position="216"/>
    </location>
  </feature>
  <feature type="mutagenesis site" description="In mutant 5M; abolished binding to lactate and protein lactylation; when associated with A-77, A-100, E-176 and A-239." evidence="19">
    <original>V</original>
    <variation>D</variation>
    <location>
      <position position="218"/>
    </location>
  </feature>
  <feature type="mutagenesis site" description="In mutant 5A; abolished binding to lactate and protein lactylation; when associated with A-46, A-77 and A-216." evidence="20">
    <original>DTG</original>
    <variation>ATA</variation>
    <location>
      <begin position="239"/>
      <end position="241"/>
    </location>
  </feature>
  <feature type="mutagenesis site" description="In mutant 5M; abolished binding to lactate and protein lactylation; when associated with A-77, A-100, E-176 and D-218." evidence="19">
    <original>D</original>
    <variation>A</variation>
    <location>
      <position position="239"/>
    </location>
  </feature>
  <feature type="mutagenesis site" description="Decreases misincorporation of Cys instead of Ala." evidence="9">
    <original>A</original>
    <variation>Q</variation>
    <location>
      <position position="448"/>
    </location>
  </feature>
  <feature type="mutagenesis site" description="Decreases editing activity." evidence="11">
    <original>C</original>
    <variation>A</variation>
    <location>
      <position position="723"/>
    </location>
  </feature>
  <feature type="mutagenesis site" description="Abolished nuclear translocation in presence of lactate." evidence="19">
    <location>
      <begin position="750"/>
      <end position="763"/>
    </location>
  </feature>
  <feature type="mutagenesis site" description="Abrogates METTL21C methylation of AARS1." evidence="14">
    <original>K</original>
    <variation>A</variation>
    <location>
      <position position="943"/>
    </location>
  </feature>
  <feature type="sequence conflict" description="In Ref. 1; BAA06808." evidence="25" ref="1">
    <original>H</original>
    <variation>Q</variation>
    <location>
      <position position="82"/>
    </location>
  </feature>
  <feature type="sequence conflict" description="In Ref. 2; BAG61157." evidence="25" ref="2">
    <original>Y</original>
    <variation>C</variation>
    <location>
      <position position="334"/>
    </location>
  </feature>
  <feature type="sequence conflict" description="In Ref. 2; BAG61157." evidence="25" ref="2">
    <original>A</original>
    <variation>T</variation>
    <location>
      <position position="763"/>
    </location>
  </feature>
  <feature type="sequence conflict" description="In Ref. 3; BAD96544." evidence="25" ref="3">
    <original>S</original>
    <variation>T</variation>
    <location>
      <position position="867"/>
    </location>
  </feature>
  <feature type="helix" evidence="40">
    <location>
      <begin position="7"/>
      <end position="20"/>
    </location>
  </feature>
  <feature type="strand" evidence="42">
    <location>
      <begin position="34"/>
      <end position="36"/>
    </location>
  </feature>
  <feature type="helix" evidence="40">
    <location>
      <begin position="45"/>
      <end position="49"/>
    </location>
  </feature>
  <feature type="helix" evidence="40">
    <location>
      <begin position="50"/>
      <end position="53"/>
    </location>
  </feature>
  <feature type="helix" evidence="40">
    <location>
      <begin position="62"/>
      <end position="65"/>
    </location>
  </feature>
  <feature type="strand" evidence="40">
    <location>
      <begin position="68"/>
      <end position="76"/>
    </location>
  </feature>
  <feature type="strand" evidence="41">
    <location>
      <begin position="78"/>
      <end position="81"/>
    </location>
  </feature>
  <feature type="helix" evidence="40">
    <location>
      <begin position="85"/>
      <end position="87"/>
    </location>
  </feature>
  <feature type="strand" evidence="40">
    <location>
      <begin position="90"/>
      <end position="93"/>
    </location>
  </feature>
  <feature type="strand" evidence="40">
    <location>
      <begin position="96"/>
      <end position="109"/>
    </location>
  </feature>
  <feature type="helix" evidence="40">
    <location>
      <begin position="111"/>
      <end position="123"/>
    </location>
  </feature>
  <feature type="helix" evidence="40">
    <location>
      <begin position="130"/>
      <end position="132"/>
    </location>
  </feature>
  <feature type="strand" evidence="40">
    <location>
      <begin position="133"/>
      <end position="138"/>
    </location>
  </feature>
  <feature type="helix" evidence="40">
    <location>
      <begin position="142"/>
      <end position="144"/>
    </location>
  </feature>
  <feature type="helix" evidence="40">
    <location>
      <begin position="150"/>
      <end position="158"/>
    </location>
  </feature>
  <feature type="helix" evidence="40">
    <location>
      <begin position="163"/>
      <end position="165"/>
    </location>
  </feature>
  <feature type="strand" evidence="40">
    <location>
      <begin position="166"/>
      <end position="169"/>
    </location>
  </feature>
  <feature type="helix" evidence="40">
    <location>
      <begin position="171"/>
      <end position="174"/>
    </location>
  </feature>
  <feature type="strand" evidence="40">
    <location>
      <begin position="178"/>
      <end position="195"/>
    </location>
  </feature>
  <feature type="helix" evidence="40">
    <location>
      <begin position="201"/>
      <end position="203"/>
    </location>
  </feature>
  <feature type="turn" evidence="40">
    <location>
      <begin position="204"/>
      <end position="207"/>
    </location>
  </feature>
  <feature type="strand" evidence="40">
    <location>
      <begin position="211"/>
      <end position="224"/>
    </location>
  </feature>
  <feature type="strand" evidence="40">
    <location>
      <begin position="230"/>
      <end position="243"/>
    </location>
  </feature>
  <feature type="helix" evidence="40">
    <location>
      <begin position="244"/>
      <end position="251"/>
    </location>
  </feature>
  <feature type="helix" evidence="40">
    <location>
      <begin position="257"/>
      <end position="259"/>
    </location>
  </feature>
  <feature type="turn" evidence="40">
    <location>
      <begin position="261"/>
      <end position="263"/>
    </location>
  </feature>
  <feature type="helix" evidence="40">
    <location>
      <begin position="264"/>
      <end position="274"/>
    </location>
  </feature>
  <feature type="helix" evidence="40">
    <location>
      <begin position="284"/>
      <end position="286"/>
    </location>
  </feature>
  <feature type="helix" evidence="40">
    <location>
      <begin position="291"/>
      <end position="310"/>
    </location>
  </feature>
  <feature type="helix" evidence="40">
    <location>
      <begin position="319"/>
      <end position="339"/>
    </location>
  </feature>
  <feature type="turn" evidence="40">
    <location>
      <begin position="343"/>
      <end position="345"/>
    </location>
  </feature>
  <feature type="helix" evidence="40">
    <location>
      <begin position="346"/>
      <end position="349"/>
    </location>
  </feature>
  <feature type="helix" evidence="40">
    <location>
      <begin position="350"/>
      <end position="357"/>
    </location>
  </feature>
  <feature type="turn" evidence="40">
    <location>
      <begin position="358"/>
      <end position="360"/>
    </location>
  </feature>
  <feature type="helix" evidence="40">
    <location>
      <begin position="362"/>
      <end position="365"/>
    </location>
  </feature>
  <feature type="helix" evidence="40">
    <location>
      <begin position="368"/>
      <end position="383"/>
    </location>
  </feature>
  <feature type="helix" evidence="42">
    <location>
      <begin position="386"/>
      <end position="399"/>
    </location>
  </feature>
  <feature type="turn" evidence="42">
    <location>
      <begin position="400"/>
      <end position="402"/>
    </location>
  </feature>
  <feature type="helix" evidence="42">
    <location>
      <begin position="408"/>
      <end position="416"/>
    </location>
  </feature>
  <feature type="helix" evidence="42">
    <location>
      <begin position="422"/>
      <end position="431"/>
    </location>
  </feature>
  <feature type="helix" evidence="42">
    <location>
      <begin position="438"/>
      <end position="450"/>
    </location>
  </feature>
  <feature type="helix" evidence="43">
    <location>
      <begin position="759"/>
      <end position="782"/>
    </location>
  </feature>
  <feature type="helix" evidence="43">
    <location>
      <begin position="789"/>
      <end position="804"/>
    </location>
  </feature>
  <feature type="helix" evidence="43">
    <location>
      <begin position="809"/>
      <end position="851"/>
    </location>
  </feature>
  <feature type="strand" evidence="43">
    <location>
      <begin position="856"/>
      <end position="861"/>
    </location>
  </feature>
  <feature type="helix" evidence="43">
    <location>
      <begin position="868"/>
      <end position="881"/>
    </location>
  </feature>
  <feature type="strand" evidence="43">
    <location>
      <begin position="886"/>
      <end position="893"/>
    </location>
  </feature>
  <feature type="turn" evidence="43">
    <location>
      <begin position="894"/>
      <end position="897"/>
    </location>
  </feature>
  <feature type="strand" evidence="43">
    <location>
      <begin position="898"/>
      <end position="904"/>
    </location>
  </feature>
  <feature type="helix" evidence="43">
    <location>
      <begin position="907"/>
      <end position="912"/>
    </location>
  </feature>
  <feature type="helix" evidence="43">
    <location>
      <begin position="916"/>
      <end position="924"/>
    </location>
  </feature>
  <feature type="turn" evidence="43">
    <location>
      <begin position="925"/>
      <end position="928"/>
    </location>
  </feature>
  <feature type="strand" evidence="43">
    <location>
      <begin position="929"/>
      <end position="933"/>
    </location>
  </feature>
  <feature type="strand" evidence="43">
    <location>
      <begin position="935"/>
      <end position="943"/>
    </location>
  </feature>
  <feature type="helix" evidence="43">
    <location>
      <begin position="945"/>
      <end position="947"/>
    </location>
  </feature>
  <feature type="helix" evidence="43">
    <location>
      <begin position="948"/>
      <end position="960"/>
    </location>
  </feature>
  <evidence type="ECO:0000255" key="1">
    <source>
      <dbReference type="HAMAP-Rule" id="MF_03133"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="2">
    <source>
      <dbReference type="PubMed" id="16139798"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="3">
    <source>
      <dbReference type="PubMed" id="19661429"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="4">
    <source>
      <dbReference type="PubMed" id="20045102"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="5">
    <source>
      <dbReference type="PubMed" id="22009580"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="6">
    <source>
      <dbReference type="PubMed" id="22206013"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="7">
    <source>
      <dbReference type="PubMed" id="24627108"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="8">
    <source>
      <dbReference type="PubMed" id="25817015"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="9">
    <source>
      <dbReference type="PubMed" id="27622773"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="10">
    <source>
      <dbReference type="PubMed" id="27911835"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="11">
    <source>
      <dbReference type="PubMed" id="28493438"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="12">
    <source>
      <dbReference type="PubMed" id="29273753"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="13">
    <source>
      <dbReference type="PubMed" id="31775912"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="14">
    <source>
      <dbReference type="PubMed" id="32611769"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="15">
    <source>
      <dbReference type="PubMed" id="33909043"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="16">
    <source>
      <dbReference type="PubMed" id="35911843"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="17">
    <source>
      <dbReference type="PubMed" id="35971119"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="18">
    <source>
      <dbReference type="PubMed" id="37106376"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="19">
    <source>
      <dbReference type="PubMed" id="38512451"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="20">
    <source>
      <dbReference type="PubMed" id="38653238"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="21">
    <source ref="26"/>
  </evidence>
  <evidence type="ECO:0000269" key="22">
    <source ref="7"/>
  </evidence>
  <evidence type="ECO:0000303" key="23">
    <source>
      <dbReference type="PubMed" id="14702039"/>
    </source>
  </evidence>
  <evidence type="ECO:0000303" key="24">
    <source>
      <dbReference type="PubMed" id="38653238"/>
    </source>
  </evidence>
  <evidence type="ECO:0000305" key="25"/>
  <evidence type="ECO:0000312" key="26">
    <source>
      <dbReference type="HGNC" id="HGNC:20"/>
    </source>
  </evidence>
  <evidence type="ECO:0007744" key="27">
    <source>
      <dbReference type="PDB" id="4XEM"/>
    </source>
  </evidence>
  <evidence type="ECO:0007744" key="28">
    <source>
      <dbReference type="PDB" id="4XEO"/>
    </source>
  </evidence>
  <evidence type="ECO:0007744" key="29">
    <source>
      <dbReference type="PDB" id="5KNN"/>
    </source>
  </evidence>
  <evidence type="ECO:0007744" key="30">
    <source>
      <dbReference type="PDB" id="5T5S"/>
    </source>
  </evidence>
  <evidence type="ECO:0007744" key="31">
    <source>
      <dbReference type="PDB" id="5T76"/>
    </source>
  </evidence>
  <evidence type="ECO:0007744" key="32">
    <source>
      <dbReference type="PDB" id="5V59"/>
    </source>
  </evidence>
  <evidence type="ECO:0007744" key="33">
    <source>
      <dbReference type="PubMed" id="18669648"/>
    </source>
  </evidence>
  <evidence type="ECO:0007744" key="34">
    <source>
      <dbReference type="PubMed" id="19413330"/>
    </source>
  </evidence>
  <evidence type="ECO:0007744" key="35">
    <source>
      <dbReference type="PubMed" id="19608861"/>
    </source>
  </evidence>
  <evidence type="ECO:0007744" key="36">
    <source>
      <dbReference type="PubMed" id="20068231"/>
    </source>
  </evidence>
  <evidence type="ECO:0007744" key="37">
    <source>
      <dbReference type="PubMed" id="22223895"/>
    </source>
  </evidence>
  <evidence type="ECO:0007744" key="38">
    <source>
      <dbReference type="PubMed" id="22814378"/>
    </source>
  </evidence>
  <evidence type="ECO:0007744" key="39">
    <source>
      <dbReference type="PubMed" id="23186163"/>
    </source>
  </evidence>
  <evidence type="ECO:0007829" key="40">
    <source>
      <dbReference type="PDB" id="4XEM"/>
    </source>
  </evidence>
  <evidence type="ECO:0007829" key="41">
    <source>
      <dbReference type="PDB" id="4XEO"/>
    </source>
  </evidence>
  <evidence type="ECO:0007829" key="42">
    <source>
      <dbReference type="PDB" id="5KNN"/>
    </source>
  </evidence>
  <evidence type="ECO:0007829" key="43">
    <source>
      <dbReference type="PDB" id="5T76"/>
    </source>
  </evidence>
  <sequence length="968" mass="106810" checksum="8683F111CEE42506" modified="2006-10-03" version="2">MDSTLTASEIRQRFIDFFKRNEHTYVHSSATIPLDDPTLLFANAGMNQFKPIFLNTIDPSHPMAKLSRAANTQKCIRAGGKHNDLDDVGKDVYHHTFFEMLGSWSFGDYFKELACKMALELLTQEFGIPIERLYVTYFGGDEAAGLEADLECKQIWQNLGLDDTKILPGNMKDNFWEMGDTGPCGPCSEIHYDRIGGRDAAHLVNQDDPNVLEIWNLVFIQYNREADGILKPLPKKSIDTGMGLERLVSVLQNKMSNYDTDLFVPYFEAIQKGTGARPYTGKVGAEDADGIDMAYRVLADHARTITVALADGGRPDNTGRGYVLRRILRRAVRYAHEKLNASRGFFATLVDVVVQSLGDAFPELKKDPDMVKDIINEEEVQFLKTLSRGRRILDRKIQSLGDSKTIPGDTAWLLYDTYGFPVDLTGLIAEEKGLVVDMDGFEEERKLAQLKSQGKGAGGEDLIMLDIYAIEELRARGLEVTDDSPKYNYHLDSSGSYVFENTVATVMALRREKMFVEEVSTGQECGVVLDKTCFYAEQGGQIYDEGYLVKVDDSSEDKTEFTVKNAQVRGGYVLHIGTIYGDLKVGDQVWLFIDEPRRRPIMSNHTATHILNFALRSVLGEADQKGSLVAPDRLRFDFTAKGAMSTQQIKKAEEIANEMIEAAKAVYTQDCPLAAAKAIQGLRAVFDETYPDPVRVVSIGVPVSELLDDPSGPAGSLTSVEFCGGTHLRNSSHAGAFVIVTEEAIAKGIRRIVAVTGAEAQKALRKAESLKKCLSVMEAKVKAQTAPNKDVQREIADLGEALATAVIPQWQKDELRETLKSLKKVMDDLDRASKADVQKRVLEKTKQFIDSNPNQPLVILEMESGASAKALNEALKLFKMHSPQTSAMLFTVDNEAGKITCLCQVPQNAANRGLKASEWVQQVSGLMDGKGGGKDVSAQATGKNVGCLQEALQLATSFAQLRLGDVKN</sequence>
</entry>
<copyright>
Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms Distributed under the Creative Commons Attribution (CC BY 4.0) License
</copyright>
</uniprot>